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Abstract 
Background Information 
The global misuse and overuse of antibiotics in human medicine and the animal production 
industry is contributing to the development of antibiotic resistance in bacteria. This is a 
serious threat to modern medicine and public health. Antibiotic resistant organisms can 
cause severe infections in humans which are difficult to treat, and in some cases impossible 
to resolve which can lead to premature death. Several studies have been conducted across 
the globe to assess the use of antibiotics in the seafood industry and the associated health 
risks, however, limited studies have recently explored this risk in an Australian setting. 
 
Aims 
This thesis aimed to investigate the presence of antibiotic residues in seafood sold in 
Western Australia. Furthermore, the occurrence of antibiotic resistance in Gram negative 
bacteria isolated from fish sold in Perth, Western Australia was assessed. The impact of 
country of origin on the presence of antibiotic residues and antibiotic resistant bacteria in 
seafood samples has also been considered. 
 
Methodology  
Historical data was accessed from the Local Health Authorities Analytical Committee 
regarding the presence of eight antibiotic types in 253 seafood samples purchased 
throughout Western Australia between May and June 2017. 
 
Forty-four fish samples, a mix of local and imported from Asian countries, were sourced from 
retail shops located in the metropolitan area of Perth between September and November 
2017. Gram negative bacteria were isolated by homogenisation of the fish with a Luria 
Bertani Broth and incubation on media selective for Gram negative bacteria. A series of 
preliminary microbial identification tests were conducted on selected bacterial isolates. 
Matrix Assisted Laser Desorption Ionization-Time of Flight confirmed the identification of the 
bacteria to species level. The identified bacteria (n = 35) were analysed for antibiotic 
susceptibility to eight antibiotic types using the standard disc diffusion method. 
 
Results  
The majority of seafood samples were free from antibiotic residue contamination and 
compliant with Australian legislation. A single non-compliant sample contained antibiotic 
residues below the level required to pose an immediate health risk to the consumer. This 
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result suggests the Australian consumer has limited risk of consuming antibiotic residues in 
seafood.    
Thirty-five Gram negative bacterial isolates from ten genera were identified. The majority of 
the antibiotic resistance observed in the bacteria was either explained by intrinsic resistance 
or was similar to previous reports. Potential acquired antibiotic resistance was observed in 
four Acinetobacter species and a Rhizobium isolate which were isolated from commonly 
farmed fish from Australia (n = 1), China (n = 1) and Vietnam (n = 3). It is possible the fish 
may have been exposed to antibiotics during the production cycle. However, this result must 
be read with caution since there are limited standardised breakpoint guidelines for these 
particular species and, therefore the results were inferred using guidelines for other, similar, 
bacterial species. 
From these results, it appears that there is limited risk to consumer health from exposure to 
antibiotic resistant bacteria via consumption of seafood, however, only a limited number of 
samples were assessed, and Gram positive bacteria were not evaluated in this study. These 
results are reassuring but suggest that vigilance is required to ensure that the risk to 
consumers is minimised. Where antibiotics are used inappropriately in environmental 
settings, the risk of environmental bacteria developing further antibiotic resistance will 
remain. Routine surveillance of antibiotic resistance in pathogenic bacteria in domestic and 
imported food of animal origin is recommended to monitor this potential risk to human public 
health. 
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Glossary 
Acceptable daily intake 
The maximum amount of an agricultural or veterinary chemical that can remain in a 
food product without causing a health risk to the consumer. It is generally provided in 
milligrams (mg) of the chemical per kilogram (kg) of the consumers body weight 
(Codex Alimentarius Commission, 2016). 
Aminoglycosides  
 A class of antibiotic drugs which act by inhibiting protein synthesis to resolve bacterial 
infection. These drugs are generally broad spectrum and active against Gram 
negative bacteria (Galbraith, Bullock, & Manias, 2004). Examples of aminoglycosides 
are streptomycin, gentamycin and kanamycin.   
Antibiotic  
An antimicrobial chemical which either kills or inhibits the growth of bacteria. This 
action can resolve and treat bacterial infection in humans and animals (Australian 
Pesticides and Veterinary Medicines Authority [APVMA], 2017). 
Antibiotic Class 
The grouping of antibiotics by their chemical properties and mechanism of action 
against bacteria (Gualerzi, Brandi, Fabbretti, & Pon, 2013).  
Antimicrobial 
 A broad term which describes an agent that halts or destroys the growth of a 
microorganism (Henriksson et al., 2018). Antimicrobials are grouped by the 
microorganism they work against. Antibiotics are antimicrobials which work against 
bacteria. Another antimicrobial is antifungals which are active against fungal growth.      
Antibiotic Resistance  
 Antibiotic resistance is when the antibacterial action of an antibiotic fails to kill or 
inhibit bacterial growth. It is a natural evolutionary process that has been accelerated 
by the overuse and misuse of antibiotics in human medicine and agriculture (Holmes 
et al., 2016). 
Antimicrobial Resistance 
 A broad term used to describe the circumstances when an antimicrobial agent no 
longer works as intended to inhibit or destroy its target microorganism (Fletcher, 
2015).  
Aquaculture 
 Also known as fish farming, is the practice of raising, breeding and harvesting aquatic 
organisms, generally for human consumption. Aquaculture occurs in fresh and salt 
water. Interventions are applied to improve production, including the application of 
feed and medicine (Sapkota et al., 2008). A variety of aquatic organisms can be 
reared in aquaculture such as species of fish, molluscs and crustacean (Food and 
Agriculture Organisation of the United Nations [FAO], 2016).  
Beta-lactam (β-lactam)  
 The categorisation of antibiotic agents chemically related with a similar molecular 
structure which contains a beta-lactam ring (Blair, Webber, Baylay, Ogbolu, & 
Piddock, 2015). See Cephalosporins and Penicillin 
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Cephalosporins 
 A class of semi-synthetic antibiotic drugs which are broad spectrum and active 
against Gram negative bacteria, they work by blocking cell wall synthesis (National 
Institutes of Health, 2017). There are five generations designed to increase 
effectiveness to treat infection. Examples of cephalosporins include cefalotin and 
cefalexin (first generation) and cefotaxime (third generation). Cephalosporins are also 
categorised as beta-lactam antibiotics. 
Critically Important Antimicrobials 
Categorised by the WHO: an antimicrobial is critically important for use in human 
medicine if it meets two sets of criteria. Firstly, it must be the only available drug to 
treat severe infections. Secondly, it must be used to treat infection caused by either 
bacteria that are transmitted to humans from non-human sources (animals, the 
environment or food), or bacteria that can potentially acquire antimicrobial resistant 
genes from non-human sources (WHO, 2017a). See Highly Important 
Antimicrobials 
Efflux Pumps 
 Are part of the bacterial cell and are responsible for transporting antibiotics out of  the 
cell, ensuring that the antibiotic does not work against the bacteria and thus, are one 
method of acquiring antibiotic resistance (Blair et al., 2015). 
Fluoroquinolones 
A group of antibiotics which are derived from quinolones by modification to include 
the addition of a fluorine atom (Gualerzi et al., 2013). They are the second generation 
onwards of the quinolone class of antibiotics, including norfloxacin and ciprofloxacin. 
See Quinolones 
Highly Important Antimicrobials  
Categorised by the WHO: antimicrobials are highly important for human medicine if 
they meet one of two sets of criteria; the first criteria, the antimicrobial must be the 
only available drug to treat severe bacterial infections and the second criteria, the 
antimicrobial must be used to treat infection caused by bacteria that are transmitted 
from non-human sources (animals, the environment or food), or from bacteria that 
can potentially acquire antimicrobial resistant genes from non-human sources (WHO, 
2017a). See Critically Important Antimicrobials 
Horizontal Gene Transfer 
 The exchange of genetic information from one bacterial organism to another bacterial 
organism. This process includes the transfer of antibiotic resistant genes between 
different bacteria. The three mechanisms of genetic exchange are conjugation (direct 
contact with other bacteria), transduction (bacteriophage mediated) and 
transformation (Deoxyribonucleic acid [DNA] uptake from the environment) (Marti, 
Variatza, & Balcazar, 2014).   
 
Inhibition Zone 
 In disc diffusion testing, it is the area directly surrounding the paper antibiotic discs on 
the surface of the agar which shows no bacterial growth. The zone diameter is 
measured and compared to guidelines to determine the susceptibility of the bacteria 
to the tested antibiotics (European Committee on Antimicrobial Susceptibility Testing 
[EUCAST], 2017).  
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Macrolides 
 A class of antibiotics which inhibit the growth of bacteria by affecting the function of 
the ribosomal subunit conducting the process of protein synthesis (Galbraith et al., 
2004). An example is erythromycin.  
Maximum Residue Limit 
 The highest level of an agricultural or veterinary chemical that is permitted to remain 
in products for human consumption as prescribed by national legislation or 
international guidelines (Codex Alimentarius Commission, 2016; Food Standards 
Australia New Zealand [FSANZ], 2018a).   
Multidrug resistance 
 The ability of a bacteria to resist the antibacterial action of two, or more, 
antimicrobials from different antibiotic classes (Qiao, Ying, Singer, & Zhu, 2018). 
Nitrofurans 
 A class of antibiotics which work by targeting bacterial DNA (APVMA, 2017). 
Examples of nitrofurans include furazolidone, nitrofurantoin and nitrofurazone. 
Pan-drug resistance 
The ability of bacteria to resist the antibacterial action of antibiotics from all 
 available antibiotic classes (Carlet, 2014).   
Penicillins  
 A class of antibiotics which act by inhibiting the synthesis of bacterial cell walls. They
 are also categorised as beta-lactam antibiotics. The first generation was derived from 
the Penicillium mould and the newer variations are semi-synthetic (Galbraith et al., 
2004). Examples of penicillins are ampicillin and amoxicillin.  
Prophylactic (Antibiotic Use) 
The misuse of antibiotics in agriculture as a preventative measure to reduce the 
chance of animals developing a bacterial infection by treating non-diseased animals 
(Economou & Gousia, 2015).  
Quinolones  
 A class of antibiotics which are synthetic drugs that act against bacteria by interfering 
with DNA synthesis (Gualerzi et al., 2013). An example is nalidixic acid.  
Sulfonamides 
 A class of synthetic antibiotics which act against bacteria by interfering with folic acid 
synthesis (APVMA, 2017). Examples include sulfadiazine, sulfamethazine and 
sulfamethoxazole. 
Tetracyclines 
 A class of antibiotics which act against a broad range of Gram negative and Gram 
positive bacteria by inhibiting protein synthesis (Gualerzi et al., 2013). Examples 
include tetracycline, oxytetracycline and doxycycline. 
Withdrawal Period 
In veterinary medicine, it is defined as the time required between the last dose of 
medication an animal receives and slaughter, to ensure that no traces of the 
medicine remain detectable in the animal’s tissue (Okocha, Olatoye, & Adedeji, 
2018).
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1.0 Introduction 
Antibiotics are antimicrobial chemicals that kill bacteria or inhibit bacterial growth and are 
therefore important drugs used in human healthcare to resolve infection (Done, Venkatesan, 
& Halden, 2015). Global overuse and misuse of antibiotics is increasing in human medicine 
and animal husbandry industries (Done et al., 2015; Laxminarayan et al., 2013). In certain 
countries the use of antibiotics in the food animal industry exceeds the amount used in 
human medicine, for example in China it is estimated that out of the total amount of 
antibiotics used, 52% are used on animals (Aitken, Dilworth, Heil, & Nailor, 2016; Qiao et al., 
2018). Antibiotics are routinely used in cattle, swine, poultry and aquatic animal farms to 
resolve illness, and to promote growth and prevent disease (Economou & Gousia, 2015). A 
number of antibiotics used in agriculture and aquaculture are also deemed as critically 
important or highly important for human medicine by the WHO, including the antibiotic 
classes of sulfonamides, tetracyclines, quinolones and penicillins (Done et al., 2015).  
 
Antibiotic resistance is a naturally occurring evolutionary process (Blair et al., 2015). 
Selective pressure created by the excessive and inappropriate use of antibiotics in hospital, 
community, agriculture and industrial settings has accelerated the prevalence of antibiotic 
resistant bacteria (Angulo, Nargund, & Chiller, 2004; Xiong et al., 2015). The term 
‘antimicrobial resistance’ is often used interchangeably with antibiotic resistance and also 
applies to eukaryotic organisms such as yeasts and protists (Fletcher, 2015).  
 
The WHO considers the spread of antibiotic resistance as one of the most significant threats 
to modern public health (Deng, Li, Zheng & Lin, 2016). Globalisation creates opportunities 
for antibiotic resistance to spread around the globe, putting all nations at risk (Barlam & 
Gupta, 2015). Resistance to all antibiotic classes has been observed in a wide range of 
bacteria, including those pathogenic to humans (Laxminarayan et al., 2013; Stein, 2011). Of 
particular concern is the emergence and spread of multidrug resistant bacteria which have 
acquired resistance to more than one antibiotic, and pan-drug resistant bacteria that 
demonstrate resistance to all available antibiotics (Capita & Alonso-Calleja, 2013). Antibiotic 
resistant infections are complicated to treat, and they often cannot be resolved, contributing 
to increased morbidity and mortality rates (Economou & Gousia, 2015).  
 
This study focusses on the use of antibiotics in the seafood industry and the associated 
public health consequences, from an Australian perspective.   
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2.0 Literature Review 
 
2.1 Antibiotic Resistance 
2.1.1 Mechanisms of Antibiotic Resistance  
Bacteria acquire antibiotic resistance by spontaneous deoxyribonucleic acid (DNA) mutation 
or horizontal gene transfer in which mobile genetic elements are exchanged through three 
main mechanisms, transformation, conjugation and transduction (Berendonk et al., 2015). 
Transformation involves the uptake of foreign DNA from the environment (Marti et al., 2014). 
Conjugation is the transfer of plasmids or transposons between bacteria in direct contact 
with each other by the formation of a sex pilus (Holmes et al., 2016). In transduction, 
bacteriophages (viruses that infect bacteria) facilitate the transfer of DNA from one bacteria 
to another (Sapkota et al., 2008). Horizontal gene transfer can occur between different 
bacterial genera as well as within a single bacterial species (Fletcher, 2015). Increased 
efficiency for horizontal gene transfer between related bacterial genera has been observed 
(Elbashir et al., 2018).  
 
Intrinsic resistance to specific antibiotics is present in many bacteria. This type of resistance 
is inherent, influenced by characteristics of the microorganisms such as their physiology and 
biochemical activity and is therefore unrelated to antibiotic exposure (Vaz-Moreira, Nunes, & 
Manaia, 2014). This innate ability can occur through the activity of efflux pumps, absence of 
drug target sites or poor permeability of the target cell wall (Capita & Alonso-Calleja, 2013). 
For example, Vancomycin is a glycopeptide antibiotic which is not able to penetrate the outer 
membrane of Gram negative bacteria due to its vast size, rendering the drug useless against 
infections caused by Gram negative bacteria (Blair et al., 2015).  
 
2.1.2 Health and Economic Impacts of Antibiotic Resistance 
Many bacteria responsible for common infections are steadily developing antibiotic 
resistance (Fletcher, 2015). In the United States of America (USA) alone, two million 
illnesses are caused by antibiotic resistant bacteria each year (Aitken et al., 2016). Antibiotic 
effectiveness is imperative to treat infections, and to prevent infection in those who have 
undergone important medical treatments or procedures such as invasive surgery (Blair et al., 
2015). Antibiotic resistant infections are challenging and expensive to resolve, leading to an 
increased burden on public health systems caused by prolonged disease duration and 
disease complication (Economou & Gousia, 2015). Further, multi and pan-drug resistant 
bacteria cause severe disease which is significantly harder to cure since there are fewer or 
no available treatment options (Laxminarayan et al., 2013). Antibiotic resistant infections are 
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often associated with premature death, contributing to increased mortality rates 
(Laxminarayan et al., 2013). It is estimated there are 700,000 deaths annually from 
antimicrobial resistance across the world (Watts, Schreier, Lanska, & Hale, 2017). It is 
projected, based on current trends, that there will be 10 million deaths globally each year 
attributed to antimicrobial resistance by 2050 (Watts et al., 2017).  
 
The economic consequences of antibiotic resistance are dire. The health care system is 
burdened by the increased cost associated with additional medical tests, longer hospitals 
stays, infection control measures and expensive alternative treatment options (Economou & 
Gousia, 2015). It is estimated the total medical cost accumulated by a hospitalised patient 
suffering from an antibiotic resistant infection can reach $29,096 USD (Capita & Alonso-
Calleja, 2013). Ineffective antibiotics are predicted to cost more than $55 billion per year 
solely in the USA, taking into account the combined cost of health care and lost productivity 
(Smith & Coast, 2013). The global cost of antimicrobial resistance is expected to rise to $100 
trillion by 2050 (Watts et al., 2017).     
 
2.1.3 Development of New Antibiotics  
Global production and discovery of new antibiotic classes has been in decline since the 
1970s (Laxminarayan et al., 2013). Pharmaceutical companies are concentrating their efforts 
in developing drugs which offer greater prospective economic returns, for instance drugs that 
must be taken daily over the course of a person’s life (Collignon, 2015). Long term profits are 
further reduced by the inevitable development of resistance to new antibiotics (WHO, 2015). 
With minimal options in line for the discovery of new drugs, the preservation of current 
available antibiotics is imperative to protect public health.    
 
2.1.4 Action Plans to Prevent Antibiotic Resistance 
Antibiotic resistance can spread across country borders through the export of goods, 
international travel of people and through environmental media such as water or soil (Barlam 
& Gupta, 2015). In 2015, the WHO adopted a global action plan on antimicrobial resistance 
with the aim to ensure that modern medicine remains a viable option to treat and prevent 
disease (WHO, 2015). Further, in 2017 the WHO developed guidelines on the use of 
medically important antimicrobials in food-producing animals, calling for a reduction or ban 
on the use of specific antibiotics across the agricultural industry, in order to preserve these 
important antibiotics for human medicine (WHO, 2017c).  
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In line with suggestions outlined by the WHO, numerous countries have developed their own 
national plans and strategies to control and monitor antibiotic resistance, including the USA 
and within the European Union (EU) (Economou & Gousia, 2015). In Australia, the 
Australian Government implemented Australia’s First National Antimicrobial Resistance 
Strategy, Responding to the Threat of Antimicrobial Resistance, which will be in effect until 
2019 (Department of Health & Department of Agriculture, 2015). The strategy outlines 
priority areas for action, advocating for a coordinated cross-sectoral response. Anticipated 
change for Australian aquaculture includes provision of an antimicrobial stewardship 
programme, implementation of guidelines for appropriate antibiotic use and the 
establishment of information for infection prevention and control options specific to the type 
of animal species (Department of Health & Department of Agriculture, 2015). 
 
2.2 Seafood Consumption Trends and Aquaculture 
Seafood is endorsed as a beneficial diet choice since it contains high levels of protein, 
vitamins and omega-3 fatty acids, which are associated with positive health benefits for the 
consumer, such as a reduced risk of heart disease (Elbashir et al., 2018). The global 
consumption of seafood per capita is increasing (FAO, 2016). In Australia, the amount of 
seafood consumed annually has increased since 2000 (Department of Agriculture and Water 
Resources [DAWR], 2015). To meet this demand, the aquaculture industry developed 
rapidly and is the fastest growing industry which produces animals for food (Boss, 
Baumgartner, & Overesch, 2016). Aquaculture, also referred to as fish farming, is defined as 
the practice of raising, breeding and harvesting aquatic organisms with the utilisation of 
interventions to improve production results (Sapkota et al., 2008). In line with global trends, 
Australia’s aquaculture industry is growing, particularly farmed salmon, prawns and oysters 
(Australian Bureau of Agricultural and Resource Economics and Sciences [ABARES], 2017).  
 
In Australia, local seafood suppliers are not able to meet the required production output 
desired by the consumer, thus 67% of the total seafood consumed in Australia in 2015-2016 
was imported (ABARES, 2017). Furthermore, imported goods from Asian countries satisfy 
the Australian consumers’ desire for cheap seafood. Developing countries generally farm 
lower-value seafood and can produce cheaper products with inexpensive labour costs and 
minimal environmental regulations, which often restrict and financially constrain production in 
developed countries (DAWR, 2015). Accordingly, the greatest volume of seafood consumed 
in Australia is sourced from Thailand, China and Vietnam (ABARES, 2017). Popular edible 
seafood imports in Australia are canned tuna, frozen prawns or shrimp and frozen fish fillets 
(Farmery, Gardner, Green, Jennings, & Watson, 2015). The most frequently consumed 
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imported fish is basa, a catfish of the Pangasiidae family, which is a low-priced, white flesh, 
boneless fish sourced from Vietnamese aquaculture (DAWR, 2015).   
 
2.3 Antibiotic Usage in Aquaculture  
2.3.1 Antibiotic Purpose 
Aquaculture practice is generally intensive to semi-intensive in nature, meaning that a high 
density of fish are stocked in small areas (Santos & Ramos, 2016). Overcrowded conditions 
are stressful for the fish, causing lowered immunity which in turn contributes to the incidence 
and spread of bacterial infections throughout the stock (Cabello, Godfrey, Buschmann, & 
Dölz, 2016). The transmission of disease in farmed aquatic animals is further facilitated by 
diminished water quality and poor hygiene practices. In certain regions, pond water is 
contaminated with uneaten food, terrestrial animal manure or faeces from the aquatic 
animals or humans (Boss et al., 2016; Mo, Chen, Leung, & Leung, 2015). Chemical and 
biological products, for example antibiotics, disinfectants and probiotics, can be applied to 
mitigate the risk of disease and to improve production (Rico et al., 2012). Antibiotics are 
often the favoured option for fish farmers since they are cost effective (Liu, Steele, & Meng, 
2017). Aquatic animals are generally medicated orally by the consumption of food mixed 
with drugs or, less commonly, animals are injected directly or dosed in a bath treatment 
(Thuy, Nga le, & Loan, 2011).  
 
Antibiotics are used to alleviate the risk of disease-related death in fish stocks (Boss et al., 
2016; Mo et al., 2015). For instance, the Chinese aquaculture industry loses roughly 7.5–15 
billion USD every year from infectious bacterial outbreaks (Liu et al., 2017). To stop the 
threat of disease, antibiotics can be used as a prophylactic over a long period of time in 
small doses (Economou & Gousia, 2015). To control an outbreak, the whole stock can be 
dosed to prevent the illness from spreading, even if only a minor portion of the stock display 
symptoms (Capita & Alonso-Calleja, 2013). Additionally, farmers are financially motivated to 
enhance production and can apply antibiotics at a low dose for growth promotion purposes 
(Cabello et al., 2013). The theory suggests constant antibiotic ingestion will maintain low 
numbers of commensal microflora in the intestines, allowing for increased absorption in the 
gut lining, thus boosting the nutrient digestibility of food and increasing weight gain in the 
animal (Mo et al., 2015). However, the success of antibiotics to increase feed efficiency and 
boost growth rates in fish has been questioned and requires further research (Done et al., 
2015). 
 
Broadly speaking, developing and developed countries have considerable differences in 
aquaculture practices (Sapkota et al., 2008). There are multiple factors related to country of 
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location that can influence a farmer’s decision to use antibiotics in aquaculture including 
legislation, knowledge, farming practices and enforcement activity (Table 1). In general, 
antibiotic use is routine in the aquaculture industry in Asian countries which produce 90% of 
the global farmed fish for human consumption (Rico et al., 2012).  
 
Table 1. Factors that may influence the likelihood of a farmer misusing or overusing 
antibiotics on the aquatic animals in aquaculture to control disease.  
Decreased likelihood  Increased likelihood  
Legislation to control use No legislation to control use 
Enforcement of legislation  No enforcement activity to control use 
Prescription only access  No requirement for a prescription for purchase 
Food testing procedures for residues No food testing procedures for residues 
Farmer knowledge of purpose of use Inadequate knowledge of purpose of use 
Labelling in the farmers language  Writing in a language foreign to the farmer 
Labelling information with directions for use Incomplete labelling information on use 
Veterinary advice available Limited access to veterinary professionals  
Hygienic facility design  Integrated fish farming with animals 
Access to vaccinations No access to vaccinations 
Clean pond water Water contaminated with agricultural waste and 
run-off 
Note. Adapted from Chuah, Effarizah, Goni, and Rusul (2016), Henriksson et al. (2018), Pruden et al. 
(2013) and Rico et al. (2012). 
 
2.3.2 Regulation and Enforcement Activity 
The use of antibiotics in the aquaculture industry is heavily regulated and controlled in 
economically developed regions, inclusive of the EU, Japan and North America (Watts et al., 
2017). Developed countries are generally guided by legislation which stipulates which 
antimicrobials can be used in aquaculture and access is limited to prescription under the 
guidance of qualified personnel (Quesada, Paschoal, & Reyes, 2013). It is usually illegal to 
apply antibiotics for growth promotion purposes in animals (Nachman, Smith, & Maron, 
2013). Developed countries enforce food testing procedures and legislative requirements 
that imported and local products must meet. For instance, aquaculture farmers outside the 
EU who wish to export their products into the EU are required to provide and implement a 
control plan for the use of veterinary products and the plan must be approved and renewed 
yearly (European Commission, 2018).  
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In contrast, antibiotic use in the Asian aquaculture industry is not always legally regulated, 
resulting in routine use (Rico et al., 2012). Asian aquaculture was established rapidly and the 
provision of legislation to control chemical use has failed to keep up with industry growth and 
regulation requirements are varied (Rico et al., 2012). In 2016, there were no legal standards 
for regulatory limits to control the presence of antibiotic residues in seafood sold in Thailand 
(Jansomboon, Boontanon, Boontanon, Polprasert, & Thi Da, 2016). Legislation in China is 
not considered stringent in comparison to the United Kingdom which has minimal legal 
options available and a broad range of antibiotics are permitted for use in Chinese 
aquaculture (Liu et al., 2017). Furthermore, there are minimal inspections of Chinese 
aquaculture farms and penalties for noncompliance are either insignificant or not actively 
enforced (Santos & Ramos, 2016).  
 
Moreover, farmers in developing countries without active regulation of the pharmaceutical 
industry are often supplied poorly labelled, low-quality or imitation antibiotics. Counterfeit 
antibiotics are commonly produced and consumed in Southeast Asia (Zellweger et al., 
2017). Poor quality drugs often fail and have been associated with contributing to the spread 
of antibiotic resistance genes (Laxminarayan et al., 2013). Misuse of antibiotics also arises 
from unclear directions on antibiotic labels, with missing information or instructions written in 
language foreign to the farmer (Rico et al., 2012).  
 
2.3.3 Knowledge and Availability  
There is a stark difference in knowledge and disease control options between the 
aquaculture industries in developed and developing countries. Developed countries are not 
as reliant on antibiotics since there are other available options to control and prevent 
disease, such as vaccination and good facility design (Pruden et al., 2013). Norway 
successfully reduced its reliance on antibiotics to control disease in salmon farms by 
implementing vaccination against disease and by improving hygiene standards across the 
board (Chuah et al., 2016). Similarly, the Tasmanian aquaculture industry is using 
significantly less antibiotics since the introduction of a vaccine implemented to prevent the 
development of diseases caused by the bacterial genera Vibrio and Yersinia (Department of 
Health & Department of Agriculture, 2015). 
 
In contrast, ease of antibiotic availability and purchase, coupled with poor understanding by 
fish farmers further exacerbates the misuse and overuse of antibiotics in developing 
countries (Uchida et al., 2016). A previous study found fish farmers could easily obtain and 
purchase antibiotics, including banned substances (Mo et al., 2015). Excessive use of 
antibiotics has been observed in Thailand and Vietnam with over 70% of fish or shrimp 
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farmers admitting to using one or more antibiotics in their production cycle (Zellweger et al., 
2017). Fish farmers in Vietnam and Thailand have demonstrated inappropriate use of 
antibiotics, without prior knowledge of the correct type of antibiotic required, dosage or 
purpose of use (Chitmanat, Lebel, Whangchai, Promya, & Lebel, 2016; Nguyen Dang Giang 
et al., 2015). A rushed decision to diagnose and treat disease can result in the application of 
unsuitable antibiotics which are ineffective to resolve the particular problem (Ryu et al., 
2012). Advice is not generally sought from veterinarians to diagnose and treat disease 
appropriately since the service is not easily accessible or it is too expensive for the farmer to 
afford (Jansomboon et al., 2016). Farmers with limited knowledge can turn to drug 
manufacturers or sellers for advice which can cause the misuse of antibiotics when the 
farmer is encouraged to purchase unsuitable antibiotics by salesmen who are solely 
motivated to make transactions for personal profit (Pham et al., 2015). Accordingly, the use 
of antibiotics in aquaculture creates a risk of antibiotic residue and antibiotic resistant 
organism contamination in the environment and seafood products.  
 
2.3.4 Integrated Farming 
The practice of integrated farming where aquaculture and agriculture co-exist is common in 
developing countries which import seafood to Australia (ABARES, 2017; Mo et al., 2015; 
Pham et al., 2015). Antibiotics are often indirectly introduced into aquatic ponds when they 
are contained in animal waste which is applied to feed the animals and encourage growth 
(Pruden et al., 2013; Watts et al., 2017). High concentrations of antibiotics have been 
reported in the waste from swine, cattle and chickens (Qiao et al., 2018; Watts et al., 2017). 
Combined farming of ducks or chickens with fish ponds often occurs where the bird pen is 
situated on top of the water with an outlet to release the manure directly into the fish pond 
(Huang et al., 2017; Watts et al., 2017). Accordingly, previous studies found higher 
concentrations of antibiotics in water at aquaculture facilities with integrated farms, in 
comparison to the water at non-integrated aquaculture facilities (Zhong et al., 2018).  
 
2.3.5 Environmental Contamination  
The majority of aquaculture facilities are connected to surrounding water sources, providing 
a contamination risk when the farm discharges wastewater (Done et al., 2015). Surrounding 
soil and sediment can become contaminated through absorption of antimicrobial agents 
expelled in wastewater (Deng et al., 2016). The water stream can also become directly 
polluted when uneaten medicated food is leached from the farm or antimicrobial metabolites 
and antimicrobial agents which are ingested but not absorbed, are excreted in animal urine, 
stools or secretions (Cabello et al., 2016). It is estimated that approximately three quarters of 
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antibiotics in feed contaminate the environment via animal excretions and uneaten feed 
(Rico et al., 2012). Waste products can be transported via underwater currents to more 
distant locations, facilitating the spread of antibiotic residues in the environment (Buschmann 
et al., 2012). 
 
It is possible for wild aquatic life in areas surrounding farms to encounter and consume 
antimicrobial agents escaped from aquaculture (Figure 1) (Cabello et al., 2013; Thuy et al., 
2011). Wild fish caught in water surrounding aquaculture facilities have been found to 
contain antibiotic residues, such as tetracyclines (Cañada-Cañada, Muñoz de la Peña, & 
Espinosa-Mansilla, 2009). Other sea animals, including crustaceans and shellfish, have also 
ingested antibiotics from the environment adjacent to aquaculture (Thuy et al., 2011). In the 
USA, farmed Atlantic salmon labelled ‘antibiotic free production’ were found to contain low 
levels of virginiamycin, an antibiotic commonly used in agriculture (Done & Halden, 2015).  
 
It can be challenging to assess the extent of antibiotic accumulation in the environment and 
the length of time they can remain active since antibiotic degradation is influenced by a 
range of factors including temperature and light (Thuy et al., 2011). Different antibiotics have 
different resistance to the biodegradation process (Mo et al., 2015). For instance, 
sulfamethoxazole has low biodegradability and as a result it can contaminate the 
environment for lengthy periods (Jansomboon et al., 2016). Oxolinic acid degrades rapidly in 
pond water which is illuminated naturally, in comparison to water with less light (Thuy et al., 
2011). Antimicrobials have been found to remain persistent for months in the environment by 
staying active in sediment (Cabello et al., 2013).  
 
2.3.6 Human Exposure to Antibiotic Residues 
Humans can be exposed to antibiotic residues via contact and consumption of wild or 
farmed aquatic organisms, and through contact with contaminated swimming and drinking 
water (Figure 1) (Chuah et al., 2016; Mo et al., 2015). Contact can occur with the polluted 
water supply or by ingestion of food containing drugs and sediment. The risk of antibiotic 
residues contaminating drinking water is considerably lower in developed countries with 
access to treated drinking water systems. The risk is increased in underdeveloped countries 
where there is limited clean and treated drinking water (Lundborg & Tamhankar, 2017; 
Quesada et al., 2013). For instance, rurally located Vietnamese drink from surface water 
which can be contaminated with antibiotics originating from agriculture (Nguyen Dang Giang 
et al., 2015). It is difficult to minimise the risk to the consumer by consumption since cooking 
does not always destroy or reduce antibiotic residues in food animals (Fletcher, 2015).  
 
 10 
 
 
Figure 1. Flow Chart outlining the entry and exit points for antimicrobials into the 
environment from aquaculture, and potential sources of human exposure. Note. Adapted 
from Chuah et al. (2016) and Mo et al. (2015). 
 
2.3.7 Adverse Drug Reaction  
Adverse drug reaction, allergic reaction or chronic toxicity, are potential negative health 
effects associated with human exposure to antibiotic residues through consumption of 
aquaculture products (Liu et al., 2017). Inadequate toxicology data and inconsistent 
standards across countries make it difficult to determine the extent of the health risk 
associated with antibiotic residues in food (Chen et al., 2015). The Codex Alimentarius 
Commission, created by the WHO and the FAO, provide some international standards for 
maximum residue limits (MRL) and acceptable daily intake (ADI) of veterinary drugs in food 
Antibiotics/ medicated 
feed application 
Fertiliser containing 
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Aquatic organism 
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of animal origin deemed acceptable to prevent risk to public health (Codex Alimentarius 
Commission, 2017). There is an additional unknown risk to human health through the 
consumption of animals contaminated with more than one antibiotic since current food safe 
guidelines are limited to providing ADI for exposure to individual antibiotics only (Zhang et 
al., 2018).  
 
There is a risk to human health if an allergic person consumes seafood contaminated with 
extremely high levels of antibiotic residues as a number of antibiotics used in the 
aquaculture industry, such as tetracycline, sulfonamides and penicillin, could initiate an 
allergic reaction in sensitive people (Liu et al., 2017; Mo et al., 2015). Potential allergic 
symptoms can include hives, abdominal pain and vomiting (Liu et al., 2017). Severe cases of 
allergic reaction can result in anaphylactic shock which may cause death (Quesada et al., 
2013). Nevertheless, it is considered an extremely rare occurrence for a person to suffer an 
allergic reaction from the consumption of meat containing antibiotic residues (Aitken et al., 
2016). For example, anaphylaxis was documented in a male who consumed steak 
contaminated with penicillin (Woodward, 2005). A similar report found a person suffered an 
allergic reaction prior to the consumption of beef contaminated with streptomycin 
(Woodward, 2005).   
 
Another risk to human health is from toxic effects in the body caused by antibiotic residues 
(Mo et al., 2015; Okocha et al., 2018). The potential negative health impacts are dependent 
on the type and concentration of the antibiotic used. For instance, erythromycin exposure 
may be linked to ototoxicity (Liu et al., 2017). Due to toxicity concerns there are restrictions 
on the use of antibiotics deemed a threat to human health. Numerous countries have 
banned the use of nitrofuran in the production of food animals due to concerns that residues 
can remain in the edible tissue of the animal, potentially triggering carcinogenic effects in 
humans when consumed, since nitrofurans have been deemed mutagenic and nephrotoxic 
(Elbashir et al., 2018; Oliveri Conti et al., 2015). Chloramphenicol is not permitted for use on 
food animals in several countries including Australia, China and the USA since aplastic 
anaemia and leukaemia have been associated with chloramphenicol exposure, and even 
low levels of exposure can be harmful (Cañada-Cañada et al., 2009; Hanekamp & Bast, 
2015; Kathleen et al., 2016; Mo et al., 2015).  
 
2.4 Australian Regulation and Control of Antibiotic Use in Food Animals 
2.4.1 Australian Regulations    
Australia has definitive national legislation to regulate drug residues in food and to oversee 
antibiotic use in the food animal industry (DAWR, 2015). Antimicrobial use in livestock 
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animals in Australia is governed and strictly controlled by the Australian Pesticides and 
Veterinary Medicines Authority (APVMA, 2017). Although there are no antibiotics registered 
for use in Australian aquaculture, the APVMA can issue minor use permits at their discretion 
(APVMA, 2017). 
 
Aquatic animals for sale for human consumption in Australia must comply with the Australia 
New Zealand Food Standards Code (ANZFSC), irrespective of the country of origin. In 
Western Australia, the Food Act 2008 (WA) and the Food Regulations 2009 (WA) adopt the 
ANZFSC. Seafood must not contain antibiotic residues unless expressly permitted, and 
within the prescribed limits, as prescribed in Standard 1.4.2 and Schedule 20 of the ANZFSC 
(Table 2) (FSANZ, 2016). Seafood for human consumption which contains traces of any 
veterinary chemicals, including antibiotics, at a concentration which is not permitted under 
the ANZFSC is deemed as unsuitable in accordance with section 13(1)(d) of the Food Act 
2008 (WA) and must not be sold. 
 
Table 2. Permitted antibiotic residues in seafood for sale in Australia. 
Antibiotic Name Type of Seafood Sample Maximum Allowable Limits (mg/kg) 
Florfenicol Fish 0.5 
Oxytetracycline Fish 0.2 
Tylosin Fish muscle 0.002 
Note. Adapted from the FSANZ (2016). 
  
2.4.2 Australian Border Testing Scheme 
The Australian Government routinely tests imported food in compliance with the Imported 
Food Control Act 1992 (Cth). The Department of Agriculture and Water Resources (DAWR, 
2015) is responsible for ensuring that imported food meets the required food safety 
standards under the ANZFSC. Under the Imported Food Inspection Scheme, seafood is 
subject to surveillance chemical tests for the presence of antibiotic residues. Each 
consignment of seafood has a 5 percent chance of being randomly selected for testing using 
electronic profiles where it is subject to testing for the presence of certain antibiotics. The 
protocol for testing differs depending on the seafood type (Table 3) (DAWR, 2016).  
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Table 3. Surveillance chemical testing conducted on imported seafood at the Australian 
border by the Department of Agriculture and Water Resources. 
Note. Adapted from the DAWR (2016). 
 
2.5 Occurrence of Antibiotic Residues in Seafood 
2.5.1 Global Studies 
A variety of antibiotics, in different concentrations, were detected in shrimps, crabs, molluscs 
and fish sold in China, Thailand, the USA, South Korea and Vietnam (Table 4) (Chen et al., 
2015; Jansomboon et al., 2016; Kang et al., 2018; Liu, Lu, Meng, & Zheng, 2018; Pham et 
al., 2015). Even antibiotics which are banned for use in aquaculture have been previously 
detected in seafood samples, such as chloramphenicol in aquatic organisms from China (Liu 
et al., 2017). The majority of the samples in the previous studies are non-compliant with 
Australian food safety legislation which stipulates that only three antibiotic types are 
permitted in seafood, any other antibiotic is not permitted at any level (Section 2.4). Of the 
32 types of antibiotics detected in global studies, only florfenicol and oxytetracycline are 
permitted, within prescribed limits, in seafood sold in Australia (FSANZ, 2016). The fish 
analysed in South Korea contained residues of florfenicol and oxytetracycline below the 
maximum allowable limits stipulated in the ANFSC, and therefore would be compliant if sold 
in Australia (Kang et al., 2018).    
 
 
 
 
 
Antibiotic Class Types of Food Antibiotic Name 
Fluoroquinolones Fish species used in aquaculture and 
farmed crustaceans 
Ciprofloxacin, enrofloxacin, 
gatifloxacin, levofloxacin, 
moxifloxacin, norfloxacin, 
ofloxacin, sarafloxacin 
Quinolones Fish species used in aquaculture Flumequine, oxolinic acid 
Nitrofurans Farmed crustaceans  Furaltadone, furazolidone, 
nitrofurantoin, nitrofurazone 
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Table 4. Antibiotic residues detected in aquatic organisms in global studies. Antibiotic types 
permitted, within limits, in seafood sold in Australia are underlined (FSANZ, 2016).      
Country of Study 
Origin of product 
Antibiotic Type Detected Aquatic Organism 
Type 
Year Reference 
China CIP, CLR, EN, ERY, FLE, 
NAR, OFL, OXY, SAL, SXZ, 
SDX, SDZ, SZE, SZO, SOX, 
TMP, 
Fish, crabs,  
molluscs and 
shrimp 
2015 Chen et al. 
(2015) 
China CIP, EN, FLU, LO, NOR, PEF Fish 2017 Song et al. 
(2017) 
China EN, SXZ, SMZ, SAR, SDZ, 
TMP, 
Fish and shrimp 2018 Liu et al., 
(2018) 
South Korea AMX, CIP, CTE, EN, ERY, 
FLO, NAL, OA, OM, OXY, 
SXZ, SMZ, SDZ, SPI, SDX, 
TET, TMP 
Fish 2018 Kang et al. 
(2018) 
Thailand 
Imported from 
Vietnam 
SMZ, SXZ, SDZ, SMY 
 
Fish 
 
 
2016 Jansomboon 
et al. (2016) 
The United States  
Mix of local and 
imported products  
OM, OXY, SDX, VI Fish and shrimp 
 
 
2015 Done and 
Halden (2015) 
Vietnam  CIP, EN, NOR, OXY Fish and shrimp 2015 Pham et al. 
(2015) 
Vietnam CIP, EN, NOR, OFL, OA, 
SMZ, SXZ, TMP 
Fish and shrimp 2016 Uchida et al. 
(2016) 
Legend (Antibiotic abbreviations): AMX, amoxicillin; CTE, chlortetracycline; CIP, ciprofloxacin; CLR, 
clarithromycin; EN, enrofloxacin; ERY, erythromycin; FLE, fleroxacin; FLO, florfenicol; FLU, 
flumequine; LO, lomefloxacin; NAL, nalidixic acid; NAR, narasin; NOR, norfloxacin; OFL, ofloxacin; 
OM, ormethoprim; OA, oxolinic acid; OXY, oxytetracycline; PEF, pefloxacin; SAL, salinomycin; SAR, 
sarafloxacin; SPI, spiramycin; SDZ, sulfadiazine; SDX, sulfadimethoxine; SZE, sulfamerazine; SMZ, 
sulfamethazine; SXZ, sulfamethoxazole; SMY, sulfamethoxydiazine; SZO, sulfathiazole; SOX, 
sulfisoxazole; TET, tetracycline; TMP, trimethoprim; VI, virginiamycin. 
 
2.5.2 Australian Studies 
In Australia, there have been limited nongovernmental studies analysing the presence of 
antibiotic residues in domestic and imported seafood. The 2016-17 National Residue Survey 
conducted by the DAWR (2017a) analysed 208 Australian fish samples for a range of 
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chemicals, including antibiotics such as aminoglycosides, cephalosporins, macrolides, 
nitrofurans, sulfonamides and tetracyclines. High levels of compliance were observed; all the 
wild caught fish (n=70) and the majority (98.55%) of the aquaculture fish (n=138) did not 
contain traces of chemical residues (DAWR, 2017a).  
 
The Australian Quarantine and Inspection Service (AQIS) survey conducted between 2006 
and 2007 assessed imported seafood products which arrived at Perth, Sydney, Melbourne 
or Brisbane for a broader range of antibiotic residues. Thirty-one percent of the 100 samples 
were found to contain residues of one or more antibiotics at levels which are too low to 
cause toxic effects in the consumer (Australian Quarantine and Inspection Service, 2008). 
The detections were non-compliant with the ANFSC which does not allow any level of 
antibiotic residues in seafood, with the exception of the samples containing oxytetracycline 
(FSANZ, 2016). The noncompliant samples all originated from five of the top six countries 
which import the greatest volume of edible seafood into Australia (Table 5).  
 
Table 5. AQIS Survey antibiotic detection results in seafood. 
Antibiotic Name Number of Detections Type of Seafood Country of Origin 
Florfenicol 1 Prawns China 
Enrofloxacin 2 Prawns China 
Ciprofloxacin 1 Prawns China 
Flumequine 6 Prawns and fish China, Indonesia, 
Thailand and Vietnam 
Oxytetracycline 7 Prawns, crab and fish China, Indonesia, 
Thailand and Vietnam 
Sulfamethoxazole 5 Prawns China 
Sulfameter 1 Eel China 
Sulfamethazine 1 Eel China 
Sulfadimethoxine 1 Eel China 
Sulfamethoxypyridazine 1 Eel China 
Amoxicillin 11 Fish and crab Indonesia and New 
Zealand 
Ampicillin 3 Fish New Zealand 
Note. Adapted from Australian Quarantine and Inspection Service (2008). 
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2.6 Antibiotic Resistance and Antibiotic Use in Aquaculture  
2.6.1 Sources of Bacterial Contamination  
Aquaculture facilities and the surrounding area host a vast range of bacterial genera 
(Kathleen et al., 2014). The bacteria can be harmless to humans or fish, or they can be 
opportunistic pathogens (Novoslavskij et al., 2016). Pathogenic bacteria in the aquatic 
environment can be naturally present such as the native habitat of Vibrio species is water 
and pathogenic strains of this species cause foodborne illness (Sudha, Divya, Francis, & 
Hatha, 2012). Pathogenic bacteria can enter the water from terrestrial sources including 
discharged industrial waste and sewerage (Cabello et al., 2016). Bacteria can potentially be 
introduced to fish ponds when human or animal faecal matter are added to the water and 
from the application of homemade fish feed made from food scraps and animal offal (Budiati 
et al., 2013; Pruden et al., 2013). Furthermore, integrated farming of livestock with 
aquaculture introduces animal manure directly into the water which creates a risk of faecal 
pathogens, such as Clostridium difficile, contaminating the fish (Putsathit, Kiratisin, 
Ngamwongsatit, & Riley, 2015; Watts et al., 2017). Aquatic organisms are at risk of bacterial 
contamination by the ingestion of polluted material or direct contact with contaminated water, 
sediment and feed (Novoslavskij et al., 2016). There is an additional risk that seafood can be 
contaminated with bacteria from improper handling and poor hygiene practices during 
transport, preparation or storage (Elbashir et al., 2018; Noor Uddin, Larsen, Guardabassi, & 
Dalsgaard, 2013).  
 
2.6.2 Bacteria Developing Antibiotic Resistance  
Bacteria can develop antibiotic resistance in response to the selective pressure created by 
the inappropriate and widespread use of antibiotics in aquaculture (Cabello et al., 2013). 
Causal relationships have been observed between the types of antibiotics used and the rise 
in resistance to these antibiotics (Ryu et al., 2012). The aquatic environment has been 
identified as a significant reservoir of antibiotic resistance genes, disseminating antibiotic 
resistance between different bacterial species (Marti et al., 2014). Mechanisms of horizontal 
gene transfer can facilitate the spread of antibiotic resistance genes between pathogenic 
and non-pathogenic bacteria (Mo et al., 2015). Multidrug resistant genes have been 
transferred to Escherichia coli (E. coli), a pathogen which causes disease in humans, from 
A. salmonicida through the mechanism of conjugation (Elbashir et al., 2018). 
 
Previous studies have identified antibiotic resistant bacteria from seafood or the aquaculture 
environment more generally in Australia, Switzerland, Korea, Vietnam, Malaysia, China, 
India and Denmark (Akinbowale, Peng, & Barton, 2006; Akinbowale, Peng, Grant, & Barton, 
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2007; Boss et al., 2016; He, Jin, Sun, Hu, & Chen, 2016; Kang et al., 2016; Kathleen et al., 
2016; Nguyen et al., 2014; Noor Uddin et al., 2013; Ryu et al., 2012; Sudha et al., 2012; 
Yang et al., 2015). A range of bacteria including potentially pathogenic species, such as E. 
coli, Vibrio, Salmonella, Pseudomonas, Serratia, Acinetobacter and Aeromonas, have 
demonstrated resistance to a variety of antibiotics from various antibiotic classes, including 
penicillins, cephalosporins, sulfonamides, aminoglycosides, tetracyclines and quinolones 
(Table 6).  
 
Table 6. Antibiotic resistance observed in bacterial isolates obtained from seafood and 
aquaculture settings, listed in alphabetical order by the country of study.  
Country of 
Study 
Bacterial genera 
or species 
Source of 
Bacteria 
Antibiotic Class Reference 
Australia Predominately 
Vibrio & 
Aeromonas 
 
Farmed fish, 
crustaceans & 
water  
AMP, AMX, CXN, CEF, 
CF, CHL, FLO, NA, OA, 
GT, KN, ERY, TET, 
OXY, TMP, SXZ, T-S 
Akinbowale et 
al. (2006) 
Australia Pseudomonas & 
Aeromonas  
Farmed fish & 
sediment 
AMX, CEF, CF, TI, 
OXY, FLO, S, SXZ, CT, 
OA, CHL, TMP, NIT 
Akinbowale et 
al. (2007) 
China Vibrio 
parahaemolyticus 
Shrimp AMP, S, RIF, SPT,  He et al. (2016) 
China Salmonella Fish, shrimp & 
oysters 
AMP, AMC, CEF, CHL, 
TET, NAL, S, KN, T-S, 
CZL 
Yang et al. 
(2015) 
China Aeromonas 
hydrophilia 
Fish AMP, CIP, KN, NAL, S, 
TET  
Yang et al. 
(2018) 
China Salmonella Fish AMP, ERY, GT, NAL, 
NIT, PEN, S, TET, TMP 
Broughton and 
Walker (2009) 
Denmark Predominately 
Pseudomonas,  
Serratia & 
Exiguobacterium 
Fish and shrimp 
from Denmark 
and imported 
from Asia 
AMP, ERY, AMC, CEZ, 
T-S, TET, CF, CT 
Noor Uddin et 
al. (2013) 
Korea Vibrio 
parahaemolyticus 
Oysters AMP, CEF, S, ERY, 
RIF, VAN 
Kang et al. 
(2016) 
Malaysia Predominately 
Bacillus, 
Staphylococcus, 
Acinetobacter & 
Pseudomonas 
Fish, shrimp, 
sediment & 
water 
S, AMP, PEN, ERY, 
CEF, RIF, NIT, PIP, 
CRO, CEZ 
Kathleen et al. 
(2016) 
India Vibrio 
parahaemolyticus 
Fish AMP, AMX, CAR, CPD, 
CEF, COL, S 
Sudha et al. 
(2012) 
South 
Korea 
Escherichia coli Fish, shellfish, 
molluscs 
& crustaceans 
TET, S, CIP, AMP, T-S, 
TI, NAL, KN, CHL 
Ryu et al. (2012) 
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Switzerland Predominately 
Escherichia, 
Enterococcus, 
Pseudomonas & 
Staphylococcus  
Fish, shrimp & 
oysters  
CIP, NAL, TET, SXZ, 
AMP, TMP, CHL, PEN, 
KN, GEN   
Boss et al. 
(2016) 
Vietnam Pseudomonas & 
Aeromonas 
Fish, water and 
sediment 
AMP, T-S, CHL, NIT, 
NAL, CIP, NOR, TET, 
DOX, GT, S, KN 
Nguyen et al. 
(2014) 
Legend (Antibiotic abbreviations): AMX, amoxicillin; AMC, amoxicillin-clavulanic acid; AMP, ampicillin; 
CAR, carbenicillin; CXN, cefalexin; CEF, cefalotin; CZL, cefazolin; CT, cefotaxime; CPD, 
cefpodoxime; CEZ, ceftazidime; CF, ceftiofur; CRO, ceftriaxone; CHL, chloramphenicol; CIP, 
ciprofloxacin; COL, colistin; DOX, doxycycline; ERY, erythromycin; FLO, florfenicol; GT, gentamicin; 
KN, kanamycin; NA, nalidixic acid; NIT, nitrofurantoin; NOR, norfloxacin; OA, oxolinic acid; OXY, 
oxytetracycline; PEN, penicillin; PIP, piperacillin; RIF; rifampicin; SPT, spectomycin; S, streptomycin; 
SXZ, sulfamethoxazole; TET, tetracycline; TI, ticarcillin; TMP, trimethoprim; T-S, trimethoprim-
sulfamethoxazole; VAN, vancomycin. 
 
2.6.3 Intestinal Microflora  
The composition of human or animal intestinal microflora can be altered by exposure to 
antibiotics (Chuah et al., 2016). A previous study found the ingestion of low-levels of 
antibiotics over extended periods of time could cause antibiotic resistance to occur in 
intestinal microflora (Liu et al., 2017). The analysis of human faecal metagenomes found 
antibiotic resistance genes were on average more frequent for antibiotics used in agriculture 
as well as human medicine (Forslund et al., 2013). Enteric bacteria harbouring antibiotic 
resistance genes can multiply in the gastrointestinal tract before they are released in the 
effluent of humans and animals, potentially disseminating in the environment, particularly in 
locations with inadequate sanitation, creating risk of human exposure and subsequent 
infection (Finley et al., 2013).  
 
2.6.4 Human Exposure and Infection 
Humans are at a risk of exposure to antibiotic resistant bacteria sourced from agriculture 
through the ingestion of contaminated products, including raw or undercooked seafood and 
drinking water (Elbashir et al., 2018). A study in the Netherlands determined similar antibiotic 
resistant genes in Enterobacteriaceae isolated from multiple hospital patients, biological 
samples and fresh meat products, suggesting a potential relationship between consumption 
and colonisation in the gut (Overdevest et al., 2011). Drinking water in less developed 
regions without adequate disinfection procedures are more likely to contain antibiotic 
resistant bacteria, particularly water which is sourced from polluted supplies tainted with 
human or animal waste (Manaia, Macedo, Fatta-Kassinos, & Nunes, 2016).  
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Populations who are at a higher risk of exposure to zoonotic, antibiotic resistant bacteria 
include farm and veterinary workers who have direct contact with contaminated animals and 
farm areas (Economou & Gousia, 2015). Antibiotic resistant bacteria can spread to hands 
and mouths by contact with contaminated surfaces, animals and excreta (Aitken et al., 
2016). Direct contact with bacteria on fish with open wounds is a risk of infection for food 
handlers or aquaculture workers (Alderman & Hastings, 1998). Cross contamination can 
occur in the kitchen transferring bacteria from raw seafood products to ready to eat foods 
(Capita & Alonso-Calleja, 2013). Poor hygiene and food handling practices, such as direct 
contact with contaminated cleaning products, handles, utensils, hands, clothing and other 
surfaces, can facilitate the spread of bacteria around the kitchen and onto food products, 
placing the consumer at risk of foodborne infection (Stein, 2011).  
 
2.7 Study Purpose and Objectives  
The majority of the seafood consumed in Australia is imported from Asian countries where 
antibiotic use is common and often unregulated (ABARES, 2017; Chen et al., 2015; 
Jansomboon et al., 2016; Oliveri Conti et al., 2015; Uchida et al., 2016). The use of 
antibiotics in aquaculture is associated with an increase in antibiotic resistant bacteria in the 
aquatic environment (Rico et al., 2013). Previous studies conducted in countries which 
supply seafood to Australia have identified antibiotic resistance in pathogenic bacteria 
isolated from seafood (ABARES, 2017; He et al., 2016; Yang et al., 2015). There is a 
potential risk to the consumer as 95% of seafood imports into Australia are not tested for 
antibiotic residues and those that are tested are only analysed for a small range of 
antibiotics, and routine Australian border testing does not analyse food of animal origin for 
the presence of antibiotic resistant bacteria (DAWR, 2016). 
 
This study was conducted to address a current gap in knowledge regarding the occurrence 
of antibiotic resistant bacteria and antibiotic residues in locally and internationally sourced 
fish sold in Australia. The objectives of this study were:  
 
 To investigate whether antibiotic residues are present in seafood for sale in Western 
Australia.  
 
 To analyse the occurrence of antibiotic resistance (8 antibiotics) in Gram negative 
bacteria isolated from fish samples sold in Perth, Australia.  
 
 To determine whether country of origin correlates with the presence of antibiotic 
residues and antibiotic resistant bacteria in seafood samples. 
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3.0 Methodology 
 
3.1 Antibiotic Residues in Seafood Data  
Historical data regarding the presence of antibiotic residues in seafood samples was 
accessed from the Local Health Authorities Analytical Committee (LHAAC) Coordinated 
Sampling Project 20, Antibiotic and Heavy Metal Residues in Seafood Products (Local 
Health Authorities Analytical Committee, 2017). Between May and June 2017, 253 samples 
of fish, crustaceans and molluscs were collected across 32 Western Australian Local 
Government areas located regionally and throughout metropolitan Perth (Figure 2).  
 
Figure 2. Map of Perth metropolitan area (red outline) within the WA map 
noting the Local Government bodies which collected seafood samples for analysis.  
Note. Adapted from Google (2018).  
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The samples were analysed by Liquid Chromatograph Triple Quadrupole Mass 
Spectrometer (LC-MS/MS) for the presence of amoxicillin, ampicillin, cefalexin, cefalotin, 
erythromycin, oxytetracycline, sulfamethoxazole and trimethoprim, above the limit of 
reporting (LOR) (Table 7). The maximum allowable limits are determined by the ANZFSC. 
Where there are no limits stipulated, then the limit of 0 mg/kg was applied since any amount 
is deemed unacceptable (FSANZ, 2016). Analysis was conducted at a National Association 
of Testing Authorities (NATA) approved laboratory (ChemCentre, Corner Manning Road and 
Townsing Drive Bentley, Western Australia). The antibiotics analysed are defined by the 
WHO as either critically or highly important antimicrobials for human medicine and should be 
used sparingly in the agriculture industry to maintain their effectiveness for treating human 
infection (WHO, 2017a). 
 
Table 7. Antibiotic type, importance classification of antibiotic by the WHO, residue LOR and 
the maximum allowable limits.  
Analyte Importance 
Classification of 
Antibiotic 
LOR 
(mg/kg) 
Maximum allowable limits (mg/kg) 
Fish Crustaceans Molluscs 
Amoxicillin Critically Important 0.02 0 0 0 
Ampicillin Critically Important 0.03 0 0 0 
Oxytetracycline Highly important 0.02 0.2 0 0 
Sulfamethoxazole Highly important 0.02 0 0 0 
Trimethoprim Highly important 0.02 0 0 0 
Erythromycin Critically Important 0.01 0 0 0 
Cefalotin Highly important 0.01 0 0 0 
Cefalexin Highly important 0.03 0 0 0 
Note. Adapted from the WHO (2017a) and FSANZ (2016). 
 
3.2 Antibiotic Resistant Bacteria from Fish  
3.2.1 Collecting Fish Samples 
Fresh and frozen fish samples were purchased from supermarkets and grocery stores 
located in ten suburbs in the metropolitan area of Perth, WA (Figure 3). Forty-four “white 
flesh” fish products were obtained, 23 of the samples were imported fish and 21 originated 
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from Australia. There was a focus on “white flesh” fish, particularly Pangasius since this type 
of fish is the most popular imported fish to eat in Australia (DAWR, 2015). The samples were 
purchased as filleted fish, the scales were already removed, and the products were pre-
packaged to minimise the risk of cross contamination from the point of sale. To maintain the 
cold-chain, the fish samples were transported in a sealed refrigerated bag containing ice 
bricks, to the laboratory at Edith Cowan University (ECU) where they were stored at 4°C in a 
sealed and labelled container for up to two days prior to processing. Some fish were 
purchased as frozen fillets and these were thawed in the refrigerator at 4°C for up to 24 
hours before bacteriological analysis. 
 
 
Figure 3. Locations in Perth, WA where fish samples were purchased. Note. Adapted from 
Google (2018).  
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3.2.2 Gram negative Bacteria Isolation  
This study focused on isolating Gram negative bacteria, members of the Enterobacteriaceae 
family, from the fish samples. Bacteria of the Enterobacteriaceae family were selected as the 
focal point of the study since they are commonly found in the aquaculture environment 
(Kathleen et al., 2014). Furthermore, the WHO identified antibiotic resistance of 
Enterobacteriaceae as a looming threat to public health. Enterobacteriaceae are classified 
priority 1 “critical” pathogens on the global priority list of antibiotic-resistant bacteria to guide 
research and the development of new antibiotics (WHO, 2017b).  
 
The fish was processed on a surface sterilised with 70% ethanol and lined with a waterproof, 
absorbent bench protector. Portions of the fish were removed aseptically with a disposable 
scalpel, placed in a sterile plastic petri dish, weighed on scales (Ripe Gourmet Kitchen 
Scales, model number 04RI150) and cut into smaller pieces using a disposable scalpel and 
a pair of forceps. The forceps were sterilised with 70% ethanol prior to use.  
 
Lennox Luria Bertani Broth (LB broth) was prepared by mixing six grams of LB powder 
(Becton Dickinson Pty Ltd, North Ryde, NSW) with 300mL of deionised water in a Schott 
bottle. Once prepared, the solution was autoclaved for 20 minutes at 121°C, under 100 kPa 
pressure. A 1:10 dilution was made in a sterile 70 mL plastic container by homogenising five 
grams of fish and 45 mL of LB broth with a Diax 900 homogeniser (Heidolph Instruments 
GmbH & Co.KG, Schwabach, Germany) using speed setting five for 90 seconds. The 
standard homogenisation process was optimised by evaluating a series of speed settings 
and times to ensure adequate homogenisation and bacteria recovery. 
 
Between each fish sample the homogeniser was completely dismantled, and all adhering 
flesh was removed, before components were sterilised using 70% ethanol. Fifty grams of the 
remaining portion of fish was stored at -18°C in a plastic zip lock bag. For back up stocks, 1 
mL of the 10% fish homogenate was transferred with a sterile micropipette into two aliquots 
and frozen in storage at -18°C, and later removed to -80°C storage. 
 
Serial dilutions of 1:100 and 1:1000 were prepared in LB broth and 100 µL of each inoculum 
was spread over the surface of MacConkey Agar (MAC) (Edwards Group Pty Ltd, Narellan, 
NSW). The prepared plates were labelled and incubated at 37°C for up to 48 hours.  
 
3.2.3 Bacteria Identification 
Following the incubation period, photographs were taken of each MAC plate and saved 
electronically for a visual record of bacterial growth (Figure 4). Bacterial colonies were 
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identified visually on the MAC for similarity in shape, colour, size, elevation, structure, and 
edges. The primary focus was to identify for the presence of Enterobacteriaceae colonies, 
specifically those that were lactose fermenting such as Escherichia species (spp.). Numbers 
of lactose fermenting, purple, and non-lactose fermenting, pink, colonies were enumerated. 
The data was recorded in an excel spreadsheet and the estimated MacConkey colony 
forming units per gram (MCFU/g) were calculated for all samples. 
 
A maximum of four different colonies grown from each fish sample were selected for further 
analysis. The selected colonies were aseptically transferred onto nonselective media, 
Trypticase soy agar (TSA) (Edwards Group Pty Ltd, Narellan, NSW), with a sterile loop and 
plated for single colonies. The TSA plates were labelled with the date of analysis and a 
reference number to identify each plate with its associated fish sample, prior to being 
incubated for up to 24 hours at 37°C (Ryu et al., 2012).  
 
 
Figure 4. Growth of bacteria isolated from fish sample 5A, diluted 1:1000, on MAC after 48 
hours incubation. 
 
3.2.3 (i) Gram Stain 
Identification tests were conducted on the bacterial isolates to confirm they belonged to the 
Enterobacteriaceae family. A Gram stain was the initial identification test conducted. This 
 25 
 
was carried out using standard methods and a Gram Stain Set (Becton Dickinson Pty Ltd, 
North Ryde, NSW). A suspension of a single bacterial colony in water was made, air dried 
and heat fixed. This smear was stained with Crystal violet for 30 seconds, flooded with 
iodine for 30 seconds, decolourised with alcohol acetone for two seconds and flooded with 
safranin for 30 seconds, with tap water being used to wash between each staining step. The 
slide was blotted dry and analysed using an Olympus CH30 microscope (Olympus 
Corporation, Tokyo, Japan) to assess the colour and shape of the bacteria using the oil 
immersion lens at x1000. Bacteria were deemed Gram positive if they appeared purple or 
Gram negative if they were pink in appearance (Becton Dickinson Pty Ltd., 2017).  
 
3.2.3 (ii) Oxidase Testing 
An oxidase test was conducted on all Gram negative bacterial isolates. Bacterial colonies 
were picked from the TSA plate with a toothpick or a plastic disposable loop and smeared 
onto a Microbact oxidase strip (Oxoid Australia Pty Ltd, Thebarton, SA). The colour of the 
strip was analysed within 5 seconds of contact with the bacteria to determine if the 
cytochrome c oxidase enzyme was produced (Thermo Fisher Scientific Inc., 2018). A deep 
blue or violet colour change was an indication that the bacteria were oxidase positive. 
Conversely, no colour change to the strip demonstrated that the bacteria were oxidase 
negative and likely from the Enterobacteriaceae family (Thermo Fisher Scientific Inc., 2018). 
 
3.2.3 (iii) Purity Plate    
One isolated colony was picked from the TSA plate with a sterile loop, emulsified in 2.5 mL 
of a sterile saline solution and then mixed to prepare a homogenous suspension. A purity 
plate was made for each isolate with 100 µL of the bacterial suspension plated on nutrient 
agar (NA) (Edwards Group Pty Ltd, Narellan, NSW). The purity plates were incubated at 
37°C for between 18 and 24 hours. 
 
3.2.3 (iv) Glycerol Stocks 
To allow storage of the organism at -80°C a heavy suspension of the bacteria from each 
purity plate was made in 800 µL LB broth, and 200 µL sterile glycerol was then added to the 
solution. The solution was labelled with the identifying number given to the bacterial isolate 
and the date of isolation and frozen at -18°C before being moved to -80°C storage.  
 
3.2.3 (v) Identification to Species Level 
Bacterial isolates identified as Gram negative and oxidase negative were initially tested with 
the Microbact 12A Biochemical Identification Kit a strip of 12 substrates used for identifying 
Enterobacteriaceae (ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) (Appendix A). 
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The microbial identify of the bacteria was then confirmed by Matrix Assisted Laser 
Desorption Ionization-Time of Flight (MALDI-TOF). The glycerol stocks containing the 
organisms were transported on ice to a research laboratory for microbial identification 
(Research Laboratory, 2nd Floor, J Block, QEII Medical Centre, Monash Avenue, Nedlands, 
Western Australia). The laboratory identified the organisms with a MALDI Biotyper which 
utilises MALDI-TOF (Bruker Daltonik, Bremen, Germany). The MALDI Biotyper CA System 
Software generates a spectrum for the tested organism which is then transformed into a 
peak list. This peak list is then compared to a database which contains peak lists for 
reference organisms (Bruker Daltonics Inc., 2018). The best match microbial identification is 
presented with a score which is used to interpret the reliability of the result (Table 8) (Bruker 
Daltonics Inc., 2018).   
 
Table 8. MALDI-TOF score value interpretation. Source: Bruker Daltonics Inc. (2018) 
Score Value Range Interpretation 
2.00 - 3.00 High confidence with the result 
1.70 - 1.99 Low confidence with the result 
< 1.70 No organism identification is possible 
 
 
3.2.4 Disc Diffusion Antibiotic Resistance Testing 
Isolates identified as Gram negative bacteria were analysed for antibiotic susceptibility to 
eight selected antibiotics using the disc diffusion method in accordance with the Disc 
Diffusion Method for Antimicrobial Susceptibility Testing manual published by the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST, 2017). A maximum of two 
different isolates from each fish sample were tested.  
 
3.2.4 (i) Antibiotic Discs 
The disc diffusion test was conducted with eight commercially available antibiotic discs 
(ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) with the following concentrations: 
ampicillin (10 μg), trimethoprim (5 μg), cefalotin (30 μg), cefalexin (30 μg), tetracycline (30 
μg), nalidixic acid (30 μg), sulfonamides (300 μg) and streptomycin (10 μg). The antibiotics 
selected were identified in previous studies as types commonly used in aquaculture or types 
that bacteria isolated from aquatic sources frequently showed resistance toward (Akinbowale 
et al., 2006; Akinbowale et al., 2007; Boss et al., 2016; He et al., 2016; Kang et al., 2016; 
Kathleen et al., 2016; Pham et al., 2015; Ryu et al., 2012; Sudha et al., 2012; Yang et al., 
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2015; Zhang, Ying, Su, Zhou, & Liu, 2013). Furthermore, all antibiotics used in this study are 
deemed as critically or highly important antimicrobials for human medicine by the WHO 
(Table 9) (WHO, 2017a).  
 
Table 9. Antibiotic types used for the disc diffusion test and their importance classification for 
human medicine determined by the WHO. 
Antimicrobial Class Drug Importance Classification 
Aminoglycosides Streptomycin Critically important 
Penicillins Ampicillin Critically important 
Quinolones Nalidixic acid Critically important 
Tetracyclines Tetracycline Highly important 
Sulfonamides Sulfonamides Highly important 
Cephalosporins  Cefalotin Highly important 
Cephalosporins  Cefalexin Highly important 
Sulfonamides Trimethoprim Highly important 
 
Note. Adapted from the WHO (2017a).  
 
3.2.4 (ii) Preparation of Inoculum and Inoculation of Agar Plates 
A suspension of bacteria in 0.85% sodium chloride was prepared to the same density as a 
McFarland 0.5 turbidity standard (EUCAST, 2017). Saline was used to adjust the density of 
the organism suspension, which was compared visually to a Remel McFarland Equivalence 
Turbidity Standard 0.5 (ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) against a 
white background with black lines (EUCAST, 2017). The organism suspension was used for 
inoculation within 60 minutes of preparation. 
 
Prior to inoculation, the Mueller-Hinton agar (MHA) plates (Edwards Group Pty Ltd, Narellan, 
NSW) were brought to room temperature and inspected to ensure that they were dry before 
being used to test the antimicrobial susceptibility of the bacterial isolates (EUCAST, 2017). A 
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sterile cotton swab was dipped into the prepared suspension and the inoculum was applied 
to the MHA to produce a lawn culture (EUCAST, 2017).  
 
3.2.4 (iii) Application of Antimicrobial Discs 
The antibiotic discs were stored at 4°C in a sealed container and were brought to room 
temperature before use (EUCAST, 2017). Each organism was inoculated onto one and a 
half MHA plates. Within 15 minutes of inoculation, sterile forceps were used to manually 
apply six antibiotic discs to the whole plate: ampicillin (10 μg), cefalotin (30 μg), cefalexin (30 
μg), tetracycline (30 μg), nalidixic acid (30 μg) and streptomycin (10 μg). Sulfonamides (300 
μg) and trimethoprim (5 μg) were applied manually with forceps to the half plate (two isolates 
per plate with a well-defined clear space between isolates). Within 15 minutes of the discs 
being applied, the plates were inverted and incubated for between 16 and 20 hours at 37°C 
(EUCAST, 2017).  
 
3.2.4 (iv) Examination of Plates After Incubation 
The plates were examined to confirm that they had been correctly inoculated, all plates 
demonstrated a confluent lawn of growth which was evenly distributed across the surface 
with circular and uniform inhibition zones (EUCAST, 2017). The inhibition zone was judged 
visually from the back of the plate over a black surface and the zone edge was measured 
with Vernier callipers. The EUCAST (2017) define the zone edge as the closest position on 
the plate where bacterial growth is completely inhibited, when viewed from a distance of 
30cm with the naked eye (Figure 5).  
 
Zone diameter interpretive standards provided by the EUCAST (2018a) and the Clinical and 
Laboratory Standards Institute (CLSI, 2018a; CLSI, 2018b) were used to classify the 
bacteria as susceptible, intermediate or resistant to the tested antibiotics (Table 10). 
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Figure 5. Disc diffusion test results on MHA demonstrating a clear zone of inhibition around 
the six antibiotic discs (left image) and no zone of inhibition surrounding the four antibiotic 
discs at the top of the plate (right image).  
 
 
Table 10. Zone Diameter Interpretive Criteria (mm) for Enterobacteriaceae  
 
Antimicrobial Agent Zone Diameter Breakpoint (nearest whole mm) Source 
Susceptible Intermediate Resistant 
Ampicillin (10μg) ≥ 14 N/A < 14 EUCAST (2018a) 
Cefalexin (30μg) ≥ 14 N/A < 14 EUCAST (2018a) 
Cefalotin (30μg) ≥ 18 15 - 17 ≤ 14 CLSI (2018a) 
Nalidixic Acid (30μg) ≥ 19 14 - 18 ≤ 13 CLSI (2018b) 
Streptomycin (10μg) ≥ 15 12 - 14 ≤ 11 CLSI (2018b) 
Sulfonamides (300μg) ≥ 17 13 - 16 ≤ 12 CLSI (2018b) 
Tetracyline (30μg) ≥ 15 12 - 14 ≤ 11  CLSI (2018b) 
Trimethoprim (5μg) ≥ 18 15 - 17 < 15 EUCAST (2018a) 
Note. Adapted from CLSI (2018a); CLSI (2018b); EUCAST (2018a). 
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3.2.5 Quality Control Tests 
Escherichia coli ATCC 25922 (E. coli ATCC 25922), Pseudomonas aeruginosa (P. 
aeruginosa ATCC 27853) and Staphylococcus epidermis (S. epidermis ATCC 12228) were 
used as quality control organisms to monitor the effectiveness of the identification tests and 
the antimicrobial sensitivity. E. coli ATCC 25922, S. epidermis ATCC 12228 and P. 
aeruginosa ATCC 27853 were subcultured onto non-selective media, TSA or NA, before 
being incubated overnight at 37°C (EUCAST, 2017).  
 
3.2.5 (i) Gram Stain  
Control smears were prepared using E. coli ATCC 25922 and S. epidermis ATCC 12228 as 
the Gram negative and positive controls respectively. The control slides were stained in 
accordance with the standard procedure before they were viewed under the oil immersion 
lens (x100, total magnification x1000) on an Olympus CH30 microscope. The staining 
procedure was determined as satisfactory if the S. epidermis on the positive control slide 
stained purple and the E. coli on the negative control slide stained pink (Becton Dickinson 
Pty Ltd., 2017; National Center for Biotechnology Information, n. d.).   
 
3.2.5 (ii) Oxidase Testing 
Each day that oxidase tests were performed, quality control tests were completed using P. 
aeruginosa ATCC 27853 as the positive control organism and E. coli ATCC 25922 as the 
negative control organism. The oxidase strips were deemed accurate if P. aeruginosa ATCC 
27853 caused a deep blue or violet colour change to the oxidase strip within five seconds, 
and no colour change occurred within five seconds after contact with E. coli ATCC 25922 
(Hardy Diagnostics, 1996).  
 
3.2.5 (iii) Disc Diffusion 
Quality control for disc diffusion was conducted each week of testing using E. coli ATCC 
25922, a recommended organism for quality control which demonstrates susceptibility to 
antibiotics (CLSI, 2018b; EUCAST, 2017). A single colony from a freshly subcultured culture 
was used to prepare a suspension for testing on MHA as described above. The newest test 
result was compared to the target range, as determined by the CLSI or the EUCAST (Table 
11) (CLSI, 2018b; EUCAST, 2018b). There was not any expected quality control range listed 
for the inhibition zone of E. coli ATCC 25922 with sulfonamides. To ensure consistency the 
zone diameter was recorded each week for this antibiotic and compared to previous results 
to analyse for any trends or deviations. 
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Table 11. Inhibition Zone Diameter Interpretive Criteria (mm) for quality control strain E. coli 
ATCC 25922.  
 
Antimicrobial Agent Inhibition Zone Diameter  
(nearest whole mm) 
Source 
Acceptable Range 
Ampicillin (10μg) 15 - 22 EUCAST (2018b) 
Cefalexin (30μg) 15 - 21 EUCAST (2018b) 
Cefalotin (30μg) 15 - 21 CLSI (2018b) 
Nalidixic Acid (30μg) 22 - 28 CLSI (2018b) 
Streptomycin (10μg) 12 - 20 CLSI (2018b) 
Sulfonamides (300μg) Not provided Not provided 
Tetracyline (30μg) 18 - 25 CLSI (2018b) 
Trimethoprim (5μg) 21 - 28 EUCAST (2018b) 
 
Note. Adapted from CLSI (2018b); EUCAST (2018b) 
 
3.3 Clostridium difficile in Fish 
Fifty grams of the frozen fish portions were transported on ice to a research laboratory and 
analysed for the presence of Clostridium difficile (Research Laboratory, 2nd Floor, J Block, 
QEII Medical Centre, Monash Avenue, Nedlands, Western Australia). Selective enrichment 
culture, polymerase chain reaction (PCR) toxin profiling and ribotyping methods were 
performed to analyse the fish samples for the presence of C. difficile (Lim, Foster, Elliott, & 
Riley, 2018).  
 
4.0 Results 
 
4.1 Data Analysis 
Results were stored and analysed in Microsoft Excel (Microsoft, Washington, United States). 
Statistical analysis was conducted using SPSS statistics software, version 25 (IBM 
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Corporation, New York, United States). The significance level for each hypothesis test was 
set at 5%.   
 
4.2 Antibiotic Residues in Seafood 
Two hundred and fifty-three seafood samples, a mix of fish (n = 176) molluscs (n = 45) and 
crustacea (n = 32) were analysed for the presence of antibiotic residues (Figure 6). The 
seafood products were from 22 countries. The largest portion of the samples were Australian 
products. The imported products were predominately from Vietnam, Thailand, New Zealand, 
Indonesia and China (Figure 6). Except for Thailand, these are the same countries that the 
fish in the antibiotic resistance testing conducted in this study were imported from (Section 
4.3.4).  
 
  
Figure 6. The portion of seafood (n = 253) categorised by fish, mollusc or crustacea (left) 
and country of origin (right).  
 
The results found high levels of compliance; the absence of antibiotic residues was observed 
in 99.6% (n = 252) of the seafood samples. One sample analysed was noncompliant, with 
erythromycin detected in excess of 0.01mg/kg in seafood sticks from Thailand. The 
proportion of samples with antibiotic residues differs from the proportion of samples without 
antibiotic resides (binomial test, p = 0.001).  
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4.3 Antibiotic Resistant Bacteria from Fish 
4.3.1 Method Validation 
A series of validation tests were conducted on three occasions to ensuring that the standard 
homogenisation process with fish did not impact on the bacterial count. An E. coli inoculum 
was prepared by dislodging half a single colony of E. coli ATCC 25922 in a 5 mL container 
with 2.5 mL LB broth. Following an incubation period for 60 minutes at 37°C (to allow 
logarithmic growth to begin), 100 µL of the E. coli inoculum was transferred with a sterile 
pipette into three separate containers (A, B and C) described below.  
 
Solution A: 100 µL of the E. coli inoculum and 50 g of LB broth. The contents were mixed 
manually with a pipette and were not homogenised.  
Solution B: 100 µL of the E. coli inoculum and 50 g of LB broth. The contents were 
homogenised using the homogenisation method described in section 3.2.2  
Solution C: 100 µL of the E. coli inoculum, 45 g of LB broth and 5 g of Basa, homogenised 
as previously described. The fish had been cooked in a frying pan prior to use to eliminate 
any viable organisms.  
 
Ten-fold serial dilutions were made up to a final dilution of 10-6 for each of the three solutions 
(A, B and C) by mixing 100 µL of the solution with 900 µL of LB broth. The dilutions were 
plated on NA in three 10 µL spots and incubated for 24 hours at 37°C. 
 
The tests were repeated three times and the log10 CFU/mL were calculated for each solution 
(Figure 7). There was no significant difference between the result for the three solutions (p= 
0.666). This demonstrates that there was no bacterial loss due to the homogenisation 
process used. Furthermore, the introduction of fish to the solution did not reduce the 
bacterial count, demonstrating that there were unlikely to be inhibitors of microbial growth 
present in the fish flesh.      
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Figure 7. Results of the blender validation tests. Note. Solution contents: Solution A (E. coli 
and LB broth, manually mixed), Solution B (E. coli and LB broth, homogenised), Solution C 
(E. coli, LB broth and Basa, homogenised) 
 
4.3.2 Microbial Growth Results 
Thirteen of the 44 fish products (29%) did not demonstrate bacterial growth on the MAC agar 
dilution plates after 48 hours incubation (Appendix B). The MCFU/g were calculated for the 
31 products with bacterial growth (Appendix B). Thirty-eight of the samples (86%) had 
bacterial growth of less than 10³ MCFU/g, the median value 4 × 10² MCFU/g is within this 
range. Of the products with bacterial growth, the lowest observed value was 102 MCFU/g 
and the highest observed value was 6.6 × 105  units. Overall the negative binomial 
regression test found there is no significant association between the country of origin 
category (Australian, n=21, vs imports, n=23) and the MCFU/g result (p=0.161).   
 
4.3.3 Microbial Identification  
Preliminary identification tests were conducted on 88 bacterial isolates with a focus on 
obtaining Gram negative isolates. Further tests were not conducted on isolates deemed to 
be Gram positive. Thirty-five presumptive Enterobacteriaceae isolates (n=35) were identified 
to species level by MALDI-TOF. The score values of the MALDI-TOF microbial identification 
all exceeded 2.0 (between 2.05 and 2.619) which demonstrates a high level of accuracy and 
confidence with the result (Appendix B).  
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The bacterial species (n=15) identified are from ten different genera of six different families 
(Figure 8 and Figure 9).  
 
 
 
 
Figure 8. The number of Gram negative bacteria (n=35) identified by genus (colour 
categorisation by family classification).  
 
 
Figure 9. The number of Gram negative bacteria (n=35) identified by species (colour 
categorisation by genus).  
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4.3.4 Fish Details 
The 35 bacterial isolates identified by MALDI-TOF were obtained from 28 different fish 
products. Seven fish samples (25%) provided two different bacterial species for analysis, 
with the remaining bacterial isolates obtained from individual fish samples. More than half of 
the products provided the fish’s scientific name accompanying the common fish name on the 
label. Scientific names which were not listed on Australian fish products were established in 
accordance with the WA Government’s fish identification guide (Department of Fisheries, 
2017). FishBase, a global database for fish species was utilised to identify the other scientific 
fish names (Froese & Pauly, 2018). The 28 fish products were from 15 different fish genera, 
the dominant fish genera were Pangasius (25%) (Table 12). Of the 28 fish which provided 
bacterial isolates, more than half (63%) originated from Australia and 37% (n=13) were 
imports from either Vietnam, Indonesia, China or New Zealand (Figure 10). 
 
 
 
Figure 10. The country of origin of the fish from which isolates were obtained. The number 
of fish in each country category is indicated to the right of the country marker. Note. Adapted 
from Google (2018).  
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Seven percent of the fish products were labelled as farmed and 14% were labelled as wild 
caught (Table 12). The majority (79%) of fish products were not labelled either wild caught or 
farmed. The fish products with missing labelling information were assumed to be farm 
produced if they were identified as common aquaculture species (Table 12). It is estimated 
that 46% of the fish products may have been farm produced. This assumption is in line with 
expectations by the FAO (2016) that approximately half of the fish consumed around the 
globe is produced by aquaculture.  
 
Table 12. Details of the fish products (n = 28) which the bacteria (n = 35) were isolated from.  
Fish (scientific name) No. 
products 
Country of 
origin 
Labelling 
(Wild/ 
Farmed) 
Aquaculture 
Species 
Reference 
Ctenopharyngodon idella 1 China Not specified  
Mo et al. (2015) 
Diagramma labiosum 1 Australia Not specified  
Froese and 
Pauly (2018) 
Epinephelus multinotatus 1 Australia Not specified  
Froese and 
Pauly (2018) 
Gymnocranius grandoculis 1 Australia Not specified  
Froese and 
Pauly (2018) 
Lethrinus nebulosus 1 Australia Not specified  
Froese and 
Pauly (2018) 
Lethrinus punctulatus 2 Australia Wild (n = 1)  
Froese and 
Pauly (2018) 
Lutjanus erythropterus 2 Australia Wild (n = 1)  
Cheng, Ma, 
Yang, Hassan, 
and Qin (2018) 
Lutjanus lemniscatus 1 Indonesia Not specified  
FAO (2018) 
Lutjanus malabaricus 1 Australia Not specified  
Froese and 
Pauly (2018) 
Lutjanus russellii  1 Australia Not specified  
Froese and 
Pauly (2018) 
Macruronus novaezelandiae 1 New 
Zealand 
Wild (n = 1)  
Froese and 
Pauly (2018) 
Mugil cephalus 1 Australia Not specified  
Froese and 
Pauly (2018) 
Nemipterus furcosus 1 Australia Not specified  
Froese and 
Pauly (2018) 
Neoarius midgleyi 1 Australia Not specified  
Froese and 
Pauly (2018) 
Ophiocephalus striatus 1 Vietnam Not specified  
Pham et al. 
(2015) 
Pangasius hypophthalmus 7 Vietnam Farmed  
(n = 2) 
 
Pham et al. 
(2015) 
Pristipomoides multidens 1 Australia Not specified  
Froese and 
Pauly (2018) 
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1 Indonesia Not specified  
FAO (2018)  
Pseudocaranx georgianus 1 Australia Wild (n = 1)  
N/A 
Seriola lalandi 1 Australia Not specified  
Froese and 
Pauly (2018) 
Legend:  = yes,  = no, N/A = not applicable.  
 
4.3.5 Antibiotic Resistance Patterns  
As expected, susceptibility patterns were different between the ten bacterial genera (Table 
13) (Kruskall-Wallis Test, p=0.002). All the isolates were susceptible to tetracycline and 
sulfonamides and the resistance to other antibiotics was varied based on the CLSI and the 
EUCAST measurement guidelines for the inhibition zone (Appendix C). Majority of the 
observed resistance was expected for the bacterial species or was similar to previous 
reports (Table 12). Potential acquired antibiotic resistance was observed in four 
Acinetobacter species and a Rhizobium isolate (Table 14).  
 
Table 13. The number of isolates in each bacterial genera resistant to antibiotics in purple 
font with antibiotic resistance which is not commonly reported and may potenially be 
acquired in bold and underlined. The number in parentheses in orange font represents the 
number of isolates with intermediate susceptibility.  
 
Bacterial Genera AMP CXN CEF NA S TMP SUL TE 
Acinetobacter (n=10) 2 7 10 1 2 10 0 0 
Serratia (n=10) 3 5 10 0 0 0 0 0 
Buttiauxella (n=4) 0 0 1 (3) 0 0 0 0 0 
Aeromonas (n=3) 3  0 2 0 0 (2) 0 (1) 0 0 
Yersinia (n=2) 1 0 1 (1) 0 0 0 0 0 
Stenotrophomonas (n=2) 1 2 2 0 1 2 0 0 
Pseudomonas (n=1) 1 1 1 0 0 0 0 0 
Rhizobium (n=1) 1 0 1 0 1 1 0 0 
Pantoea (n=1) 0 0 0 0 0 0 0 0 
Pluralibacter (n=1) 0 0 0 0 0 0 0 0 
 
Legend: AMP = ampicillin, CXN = cefalexin, CEF = cefalotin, NA = nalidixic acid,  
S = streptomycin, TMP = trimethoprim,  SUL =  sulfonamides, TE = tetracyline. 
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Table 14. Bacterial isolates with potential acquired antibiotic resistance. 
 
Bacterial Species 
 
Antibiotic Type/s 
Fish Details 
Scientific Name Country of 
Origin 
Farmed or 
Wild* 
Acinetobacter 
haemolyticus 
Ampicillin  Lutjanus 
erythropterus 
Australia Farmed 
Acinetobacter 
haemolyticus 
Ampicillin and 
streptomycin 
Pangasius 
hypophthalmus 
Vietnam Farmed 
Acinetobacter 
ursingii 
Nalidixic acid Ophiocephalus 
striatus 
Vietnam Farmed 
Acinetobacter 
haemolyticus 
Streptomycin Pangasius 
hypophthalmus 
Vietnam Farmed 
Rhizobium 
radiobacter 
Trimethoprim Ctenopharyngodon 
idella 
China Farmed 
 
*Source: Cheng et al. (2018); Mo et al. (2015); Pham et al. (2015) 
 
 
4.3.6 Country of Origin 
Of the ten bacterial genera identified, Serratia and Acinetobacter were the two genera which 
contained bacterial isolates obtained from a mix of Australian and imported fish (Table 15). 
The Acinetobacter strains were isolated from fish samples which originated from Australia (n 
= 3) and overseas (Indonesia, n = 1 and Vietnam, n = 6). The Serratia strains were isolated 
from fish which originated from Australia (n = 8) and overseas (New Zealand, n = 1 and 
Vietnam, n= 1).  
 
Table 15. Acinetobacter and Serratia isolates resistant to antibiotic types, categorised by the 
origin of the fish.   
 
Bacterial Genera Antibiotic resistance  Australian (n) Imported (n) 
Acinetobacter Cefalotin 3 (3) 7 (7) 
Trimethoprim  3 (3) 7 (7) 
Cefalexin 3 (3) 4 (6) 
Ampicillin 1 (3) 1 (7) 
Streptomycin 0 (3) 2 (7) 
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Nalidixic Acid  0 (3) 1 (7) 
Serratia  Cefalotin 8 (8) 2 (2) 
Ampicillin 3 (8) 0 (2) 
Cefalexin  4 (7) 1 (2) 
 
4.3.7 Quality Control: Standard Antimicrobial Test  
The disc diffusion test was performed on eight occasions for quality control (Appendix D). 
The zone diameter results were always consistent with the target range for E. coli ATCC 
25922 as determined by available ranges provided by the EUCAST and CLSI. Although 
there is no available target range for sulfonamides, all results were consistent and within 
3mm of each other. The overall finding validated the performance of the disc diffusion 
method, the results obtained, and the quality of the materials used.  
 
4.4 Clostridium difficile in Fish 
C. difficile was not detected in the 44 fish samples (Appendix B).  
 
 
5.0 Discussion 
 
5.1 Antibiotic Residues in Seafood 
5.1.1 Seafood Sold in Australia 
This study determined the concentration of the eight antibiotics tested for were below the 
LOR in 99.6% (n = 252) of the Australian sold seafood samples. All the seafood samples 
originating from Australia were compliant. One imported sample contravened the ANZFSC 
with the detection of erythromycin in seafood sticks originating from Thailand. The country of 
origin of the seafood with the non-compliant antibiotic residue result is unsurprising. The use 
of erythromycin in Thailand aquaculture has been previously reported (Rico et al., 2012).  
 
The high levels of compliance observed in the domestic seafood products analysed in our 
study are in line with findings from the Australian Government’s 2016-17 National Residue 
Survey which found 99% of Australian domestic fish samples did not contain veterinary 
medicine residues (DAWR, 2017a). The testing protocol in the National Residue survey 
differs per product type. For example, Australian barramundi raised in aquaculture settings 
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are tested for residues of 52 antibiotics including amoxicillin, ampicillin, oxytetracycline, 
sulfamethoxazole and trimethoprim (DAWR, 2017b). Compliance rates with Australian 
legislation observed in the National Residue Survey have remained consistently high over 
the past four years. The 2014-15 survey and the 2015-16 survey both found 100% of 
Australian aquaculture and wild caught seafood samples were free from antibiotic residue 
contamination (DAWR, 2017a).  
 
However, it is an unexpected result that there was only one non-compliant result from the 
seafood samples imported into Australia. The AQIS survey conducted in 2006 and 2007 
found quantifiable levels of antibiotic residues in 31% of imported seafood (n = 100) from 
Asian countries and New Zealand (Australian Quarantine and Inspection Service, 2008). 
Ampicillin was detected in three fish samples in concentrations ranging from 10 - 130 µg/kg 
and amoxicillin was detected in 11 fish and crab samples at a concentration between 14 - 
380 µg/kg. In contrast, our study did not find any seafood containing amoxicillin or ampicillin 
in excess of 20 µg/kg and 30 µg/kg, respectively. It is important to note that the AQIS survey 
analysed seafood for a broader range of antibiotics (n = 40) in comparison to the current 
study (n = 8). As a result, the AQIS survey detected increased non-compliant results with 
residues of eight antibiotic types that our study did not analyse for. Furthermore, it is 
possible that the AQIS found significantly higher levels of non-compliance due to a lower 
LOR in the testing laboratory. For instance, AQIS detected oxytetracycline (2 - 8.6 µg/kg) 
and sulfamethoxazole (2.3 - 5.4 µg/kg) in concentrations which were below the lower LOR 
applied in our study (20 µg/kg). Nevertheless, based on the antibiotic types which can be 
compared, our finding suggests imported seafood has improved compliance with Australian 
food legislation as compared to 2006. 
 
5.1.2 Country of Origin  
The concentration of eight antibiotics were below the LOR in 99.6% (n = 252) of the seafood 
samples. One sample from Thailand contained traces of one antibiotic. The overall high 
levels of compliance in this study suggest that country of origin does not seem to correlate 
with the presence of antibiotic residues in food sold in Australia.   
 
This result is surprising since antibiotic use is excessive and frequent in Asian aquaculture 
(Pruden et al., 2013; Rico et al., 2012). As a result, antibiotic residue contamination has 
been found in seafood obtained in China, Vietnam, Thailand and South Korea (Jansomboon 
et al., 2016; Kang et al., 2018; Song et al., 2017; Uchida et al., 2016). It is possible there are 
different production standards in Asian aquaculture, influenced by whether the prospective 
buyer is domestically or internationally located (Uchida et al., 2016). Fish farmers intending 
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to export products to developed countries are forced to comply with regulated veterinary 
residue limit requirements and stringent border testing procedures, or they risk jeopardizing 
their businesses (Pham et al., 2015). In contrast, Asian farmed seafood intended for 
domestic sale are at a risk of containing increased levels of antibiotic residues since there is 
less stringent legislation and limited government testing to control the presence of antibiotics 
in food locally (Henriksson et al., 2018; Zellweger et al., 2017). Shrimp farmed in Thailand 
that is intended for export overseas and fails internal tests for antibiotic residue 
contamination is sold to the Thai domestic market (Holmström et al., 2003).   
 
5.1.3 Health Risk (Adverse Drug Reaction) within Australia 
The one non-compliant result detected in seafood sticks from Thailand contained 
erythromycin in a concentration of 10 µg/kg. Oral exposure to erythromycin may cause 
ototoxicity or peripheral neuritis, however, the concentration of erythromycin detected in this 
study would not cause a risk of adverse drug reaction to the consumer (Codex Alimentarius 
Commission, 2017; Liu et al., 2017). The maximum ADI of erythromycin stipulated by the 
Codex Alimentarius Commission was 0.7 µg/kg body weight, which equates to 60.2 µg per 
day for the average Australian male, weighing 86 kg, and 49.8 µg per day for the average 
Australian woman, weighing 71.1 kg (Australian Bureau of Statistics, 2013; Codex 
Alimentarius Commission, 2017). Therefore, the concentration of erythromycin detected in 
this study does not pose an immediate health risk to the average Australian adult. A person 
would have to consume approximately 5 - 6 kg of contaminated fish sticks a day to exceed 
the safe ADI, which is unlikely. In contrast to our finding, a study in China detected 
erythromycin in shrimp samples at a concentration of up to 15,090 µg/kg, which exceeds the 
Codex Alimentarius Commission’s MRL and safe daily limit for the average person, risking 
harm to the consumer (Chen et al., 2015).   
 
Although a direct risk to consumer health from antibiotic residues was not demonstrated, 
there is still a potential risk to the health of the Australian consumer in two ways. Firstly, 
seafood sold in Australia may be contaminated with antibiotic types that were evaluated in 
this study. There are numerous other antibiotics which have been identified as being used in 
overseas aquaculture resulting in pollution of the aquatic environment and aquatic 
organisms (Kang et al., 2018; Zhong et al., 2018). Secondly, our study was not able to 
confirm that the aquatic organisms were produced in an antibiotic free environment. 
Antibiotic residues are not likely to remain in the animal’s edible tissue if the farmer waits the 
withdrawal time prescribed by the drug manufacturer prior to harvesting the animal for 
human consumption (Okocha et al., 2018). For instance, a recent study determined that 
prawns orally dosed with antibiotics have a minimal chance of the drug remaining in the 
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body tissue following a withdrawal period of three weeks (Sun et al., 2016). It is therefore 
possible that the seafood sold in Australia was previously exposed to antibiotics. Antibiotic 
resistance studies on bacteria isolated from aquatic animals is the best method to assess 
the level of risk posed to the consumers’ health via this pathway.  
 
5.2 Antibiotic Resistance in Bacteria Isolated from Fish  
The range of bacteria identified in our study, 15 species from ten genera, is not unusual 
since aquatic organisms are known to contain multiple bacterial genera, attained from their 
surrounding aquatic environment (Novoslavskij et al., 2016). The ten bacterial genera 
identified in this study, Acinetobacter, Serratia, Buttiauxella, Aeromonas, Stenotrophomonas, 
Yersinia, Pantoea, Pluralibacter, Pseudomonas and Rhizobium, are not the typical strains 
analysed in antimicrobial susceptibility studies which often focus on common foodborne 
pathogens found on fish such as E. coli, Vibrio and Salmonella (Elbashir et al., 2018; He et 
al., 2016; Kang et al., 2016; Ryu et al., 2012; Yang et al., 2015; Zhang et al., 2013). It is 
surprising that Vibrio were not identified in our study since a higher prevalence of Vibrio has 
previously been detected in fish samples (45.1%) and seafood samples (92%) (Sudha et al., 
2012; Woodring et al., 2012). The absence of other pathogenic Enterobacteriaceae is typical 
since they are less commonly reported on seafood, for example a previous study found 6.7% 
of seafood samples were contaminated with E. coli (Ryu et al., 2012; Yang et al., 2015). The 
most common bacteria identified in our study were Acinetobacter spp. (28.6%) and Serratia 
spp. (28.6%). In comparison, a previous study on bacteria isolated from seafood found 13% 
were Serratia and Acinetobacter made up less than 5% of the total isolates from seafood 
(Noor Uddin et al., 2013). 
 
All 15 identified bacterial species were Gram negative, which are ubiquitous in the 
environment and have varied potential pathogenicity to humans (Table 16). 
 
 
 
 
 
 
 
 
Table 16. Characteristics by bacterial genera. 
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 Habitat Pathogenicity  
 Soil or 
Water 
Potential 
Human 
Pathogen 
Foodborne 
Infection 
Wound 
Infection 
(Community 
acquired) 
Hospital 
acquired 
infection  
Reference 
Acinetobacter 
(A. haemolyticus, A. 
junii and A. ursingii) 
 
     Maravić et al. 
(2016). 
 
Aeromonas 
(A. hydrophila and 
A. salmonicida) 
 
     Janda and 
Abbott (2010) 
Stenotrophomonas 
(S. maltophilia) 
 
      Brooke (2012) 
Rhizobium 
(R. radiobacter), 
 
  a    a Mihaylova, 
Genov, and 
Moore (2014) 
Serratia  
(S. liquefaciens and 
S. fonticola) 
 
     Mahlen 
(2011) 
Yersinia 
(Y. kristensenii, and 
Y. intermedia) 
 
  a    Novoslavskij 
et al. (2016) 
Pseudomonas 
(P. alcaligenes) 
 
  a    a Xu, Zeng, 
Jiang, Zhou, 
and Zeng 
(2015) 
Buttiauxella 
(B. agrestis) 
  a   a  Antonello et 
al. (2014) 
Pantoea 
(P. agglomerans) 
 
  a   a  a Saticioglu, 
Duman, and 
Altun (2018) 
Pluralibacter 
(P. gergoviae) 
 
  a    a Whitman 
(2015) 
Legend:  = yes,  = no,  a  = rarely reported or limited information is available,  
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5.2.1 Acinetobacter species 
Acinetobacter spp. are often found in wet habitats including ponds, fish farms and seawater 
and sewerage (Wong et al., 2017). Acinetobacter spp. are generally opportunistic pathogens 
which cause nosocomial infections which are often transmitted in intensive care facilities 
(Gillespie & Hawkey, 2006). The three species identified in this study, A. haemolyticus (n=8), 
A. junii (n=1) and A. ursingii (n=1), are potential human pathogens (Maravić et al., 2016). 
The most clinically significant species of Acinetobacter, A. baumanii, was not identified.  
 
The susceptibility results obtained in this study must be read with caution. There are limited 
breakpoint guidelines for Acinetobacter spp. and seven of the antibiotics tested do not have 
established breakpoints meaning that they are not commonly used clinically to control 
infections caused by this species. Tetracycline, the sole antibiotic from this study with 
guidelines for Acinetobacter spp., has the same diameter interpretive criteria as outlined for 
Enterobacteriaceae (CLSI, 2018b). The susceptibility results for Acinetobacter spp. with the 
antibiotics which do not have breakpoints were interpreted based on CLSI and EUCAST 
breakpoints for Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a).  
 
In this study, antibiotic resistance was commonly demonstrated among Acinetobacter spp., 
with all isolates (n=10) resistant to at least two antibiotics. Resistance was observed to 
cefalotin (100%), cefalexin (70%), trimethoprim (100%), nalidixic acid (10%), ampicillin 
(20%) and streptomycin (20%). This finding is in line with expectations for this genus which 
is often highly resistant to many antibiotics, due to acquired and intrinsic resistance 
mechanisms (Richard & Yitzhak, 2014). Acinetobacter spp. have the capacity to rapidly 
develop antibiotic resistance by acquiring resistant genes obtained from mobile genetic 
elements transferred from other bacterial species (Walker, 2007). Environmental strains of 
Acinetobacter spp. are significant reservoirs of antibiotic resistance in the environment and 
evaluation of these strains may provide evidence for increasing antibiotic resistance (Wong 
et al., 2017).  
 
Cefalotin: High levels of resistance in Acinetobacter to cephalosporins is to be expected 
since rates of resistance to first generation cephalosporins, such as cefalexin and cefalotin, 
have been rising since the 1970’s (Vikas, Sinha, & Singh, 2010). The resistance to cefalotin 
(100%) identified by this study has slightly increased in comparison to the results from a 
study in 1971 conducted in the US which found that 77% of clinical strains of A. 
haemolyticus (n=38) were resistant to cefalotin (Gilardi, 1971). More recently, a French 
study found clinical isolates of A. ursingii were all resistant to cefalotin (Dortet, Legrand, 
Soussy, & Cattoir, 2006). 
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Trimethoprim: The resistance to trimethoprim (100%) is usual for Acinetobacter species. A 
previous study in France similarly found 70% of clinical A. ursingii isolates were resistant to 
trimethoprim, with the remaining 30% demonstrating intermediate susceptibly (Dortet et al., 
2006). Resistance in Acinetobacter spp. to trimethoprim has been attributed to efflux pumps 
with acquisition via horizontal gene transfer (Van Looveren & Goossens, 2004). 
 
Nalidixic acid, ampicillin and streptomycin: The resistance observed to nalidixic acid 
(10%), ampicillin (20%) and streptomycin (20%) in this study is likely acquired. Nalidixic acid, 
ampicillin and aminoglycosides, including streptomycin were used in the early 1970’s to 
successfully resolve Acinetobacter infections (Dalla-Costa et al., 2003; Van Looveren & 
Goossens, 2004). Since then, resistance has been rising to these antibiotic classes (Van 
Looveren & Goossens, 2004). A. ursingii (n = 1) isolated from snakehead fish 
(Ophiocephalus striatus) was resistant to nalidixic acid and A. haemolyticus (n = 2) isolated 
from catfish (Pangasius hypophthalmus) were resistant to streptomycin. It is likely that these 
fish from Vietnam were farm produced since catfish and snakehead are among the most 
common fish species which are grown in aquaculture in Vietnam (Pham et al., 2015). 
Streptomycin is used in Vietnamese aquaculture and nalidixic acid is a common antibiotic 
used in the countries with the largest aquaculture production, inclusive of Vietnam (Done et 
al., 2015; Rico et al., 2012).  
 
Resistance to ampicillin was observed in two A. haemolyticus isolates, one from catfish 
(Pangasius hypophthalmus) originating from Vietnam and the other from crimson snapper 
(Lutjanus erythropterus) from Australia. Ampicillin is frequently used in Vietnamese 
aquaculture including in the production of catfish (Pham et al., 2015; Rico et al., 2012). In 
Vietnam, the use of ampicillin is permitted with limited use in aquaculture to treat disease 
(Binh, Dang, Anh, Ky, & Thai, 2018). Crimson snapper is a significant fish species for 
aquaculture in Australia and Asia (Cheng et al., 2018). Ampicillin is not permitted for use in 
Australian aquaculture but is permitted for therapeutic use in Australian cattle and sheep 
(APVMA, 2014). It is possible that the crimson snapper was exposed to contaminated 
agricultural waste containing ampicillin residues or that ampicillin was used illegally to treat 
disease in fish.  
 
5.2.2 Aeromonas species 
Aeromonas spp. are naturally found in brackish and fresh water, and soil (Bhatia, Castro-
Borobio, Greene, & Nanjappa, 2017). Accordingly, this species has previously been isolated 
from the aquaculture environment, fish and invertebrates (Piotrowska & Popowska, 2014). A. 
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hydrophila (n = 2) and A. salmonicida (n = 1), found in this study, cause disease in humans 
and fish, respectively (Janda & Abbott, 2010). Although healthy populations are at risk of 
infection from exposure, immunocompromised individuals are at a greater risk of developing 
serious complications (Janda & Abbott, 2010). A broader range of health impacts have been 
associated with this bacterium including wound infection, however, gastrointestinal illness is 
the most common infection in humans (Clark & Chenoweth, 2003; Whitman, 2015). 
Outbreaks of gastrointestinal illness have been caused by the ingestion of raw fish 
contaminated with A. hydrophila (Praveen Kumar, Chanchal, Shashank, Nirupama, & 
Subha, 2016) 
 
The susceptibility results obtained in this study should be interpreted cautiously as seven of 
the antibiotics tested do not have established breakpoints. Tetracycline is the sole antibiotic 
from this study with established zone diameter guidelines for Aeromonas spp., including A. 
hydrophila, where interpretive criteria are the same as Enterobacteriaceae (CLSI, 2010). Our 
Aeromonas spp. were susceptible to tetracycline. Other antibiotic results were inferred using 
interpretation criteria based on CLSI and EUCAST breakpoints for Enterobacteriaceae 
(CLSI, 2018b; EUCAST, 2018a).  
 
Ampicillin: All the Aeromonas spp. (n = 3) isolated in this study demonstrated resistance to 
ampicillin. This is expected for Aeromonas spp. which are typically resistant to ampicillin and 
penicillin (Bhatia et al., 2017; CLSI, 2010; Whitman, 2015). These data are comparable to 
previous studies conducted on Aeromonas spp. isolated from seafood. Resistance to 
ampicillin was found in 100% of Aeromonas isolates from fish in Malaysia (Radu, Ahmad, 
Ling, & Reezal, 2003), 93.5% of Aeromonas isolates from catfish in Vietnam (Nguyen et al., 
2014), 86% of Aeromonas spp. isolated from fish in Australia (Akinbowale et al., 2006) and 
89% of Aeromonas spp. isolated from seafood in Thailand (Woodring et al., 2012).  
 
Cefalotin: This study found two Aeromonas isolates (A. hydrophila and A. salmonicida) 
isolated from the same fish (Lethrinus punctulatus) demonstrated resistance to cefalotin. The 
resistance to cefalotin is expected since many Aeromonas spp. are resistant to first- 
generation cephalosporins due to the production of enzymes that deactivate beta-lactam 
antibiotics (Clark & Chenoweth, 2003; CLSI, 2010). Previous Australian studies found 
between 46 and 85% of Aeromonas spp. isolated from fish were resistant to cefalotin 
(Akinbowale et al., 2006; Akinbowale et al., 2007). 
 
Streptomycin, trimethoprim, nalidixic acid and tetracycline: In this study, two 
Aeromonas spp. had intermediate susceptibility to streptomycin and one Aeromonas isolate 
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had intermediate susceptibility to trimethoprim. Compared to previous findings, this 
demonstrates a reduction in antibiotic resistance. Streptomycin resistance was observed in 
31% of Aeromonas isolates obtained from catfish in Vietnam (Nguyen et al., 2014). 
Aeromonas isolates from a Turkish fish market were all found to demonstrate resistance 
against trimethoprim (Praveen Kumar et al., 2016). Furthermore, our study found no 
resistance in Aeromonas to nalidixic acid and tetracycline. This is an improved result 
compared to previous studies in China and Vietnam which found resistance in Aeromonas 
isolated from fish to nalidixic acid (52 - 73%) and tetracycline (34 - 89%) (Nguyen et al., 
2014; Yang et al., 2018). The variation in results is likely due to differences in how the fish 
were produced. The Aeromonas in our study were isolated from fish species (Lutjanus 
russellii and Lethrinus punctulatus) that are commonly wild caught off the coast in North 
Western Australia, as opposed to the other studies which predominantly isolated Aeromonas 
from catfish and grass carp, fish species that are commonly farmed Asia and are likely 
exposed to antibiotics during production (Department of Fisheries, 2017; Pham et al., 2015)  
 
5.2.3 Stenotrophomonas species. 
Stenotrophomonas spp. are environmental bacteria and the species identified in this study, 
S. maltophilia, has previously been isolated from a range of seafood (Abraham, Paul, 
Adikesavalu, Patra, & Banerjee, 2016; Falagas, Kastoris, Vouloumanou, & Dimopoulos, 
2009). S. maltophilia is an opportunistic human pathogen, immunocompromised individuals 
are at the greatest risk of developing hospital-acquired infections and, less frequently, 
community-acquired infections, including wound infection (Brooke, 2012; Falagas et al., 
2009). This organism can cause infection throughout the body, including in the lungs, blood, 
eyes, urinary tract (UTI) and brain (Abraham et al., 2016).  
 
EUCAST provide susceptibility breakpoint guidelines only for co-trimoxazole for 
Stenotrophomonas spp. since it is the preferred antibiotic treatment for S. maltophilia 
infections (Kim et al., 2018). The antimicrobial susceptibility results for S. maltophilia were 
inferred using interpretation criteria based on CLSI and EUCAST breakpoints for 
Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a). Therefore, the results for other agents 
in this study must be interpreted carefully (Abbott, Slavin, Turnidge, Thursky, & Worth, 2011; 
EUCAST, 2012).  
 
Cefalotin, cefalexin, trimethoprim, streptomycin and ampicillin: The S. maltophilia 
isolates (n=2) in this study were resistant to five antibiotics, cefalotin (100%), cefalexin 
(100%), trimethoprim (100%), streptomycin (50%) and ampicillin (50%). This species is 
known to demonstrate resistance to a broad range of antibiotics (Brooke, 2012; Falagas et 
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al., 2009). The CLSI (2018b) standards state that S. maltophilia is intrinsically resistant to 
cefalotin, cefalexin, trimethoprim, ampicillin, and the aminoglycoside class of antibiotics, 
which includes streptomycin. Intrinsic antibiotic resistance in S. maltophilia can be attributed 
to low membrane permeability, beta-lactamases, modifying enzymes and efflux pumps 
(Abbott et al., 2011). S. maltophilia is also known to acquire antibiotic resistance from other 
bacteria in the environment (Brooke, 2012).  
 
Tetracycline: Against expectations, S. maltophilia in this study were susceptible to 
tetracycline (CLSI, 2018b). This result is unsurprising for the S. maltophilia isolated from the 
sweetlips snapper (Lutjanus lemniscatus) imported from Indonesia since this fish is not a 
species commonly farmed in this location (FAO, 2018). The susceptibly to tetracycline 
observed in the S. maltophilia isolated from catfish (Pangasius hypophthalmus) imported 
from Vietnam is a surprise since this fish is one of the top farmed species in Vietnam and a 
previous study found 29% of Vietnamese aquaculture farms used tetracycline in their 
production (Nguyen Dang Giang et al., 2015).  
 
5.2.4 Rhizobium species 
Rhizobium spp. are present throughout the environment especially in soil and plants (Lai et 
al., 2004; Sood, Nerurkar, & Malvankar, 2010). Rhizobium spp. are not often associated with 
aquatic environments, suggesting soil contamination has occurred. Rhizobium radiobacter, 
also known as Agrobacterium radiobacter, is a rare, opportunistic human pathogen which 
causes hospital and community acquired disease, particularly in immunocompromised 
people (Lai et al., 2004). Although R. radiobacter can cause bacteraemia, UTI and 
pneumonia, it is considered of low medical importance since it is uncommon and has low 
virulence (Mihaylova et al., 2014; Sood et al., 2010). Foreign objects introduced into the 
body, often catheters, are regularly associated with R. radiobacter infection (Kaselitz, 
Hariadi, Lipuma, & Weinberg, 2012; Sood et al., 2010).  
 
There are limited standardised breakpoint guidelines for Rhizobium species. Therefore, the 
antimicrobial susceptibility results for Rhizobium spp. were inferred using interpretation 
criteria based on CLSI and EUCAST breakpoints for Enterobacteriaceae (CLSI, 2018b; 
EUCAST, 2018a). Consequently, the susceptibility results obtained in this study must be 
read with caution.  
 
Cefalotin, ampicillin, streptomycin and trimethoprim: The R. radiobacter isolate in this 
study (n=1) demonstrated resistance to cefalotin, ampicillin, streptomycin and trimethoprim. 
The results are within expectations since there is often a wide variation in susceptibility 
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patterns to antibiotics between Rhizobium strains (Chen, Hansen, & Hansen, 2008). It is 
suggested that R. radiobacter may develop resistance to multiple antibiotics from contact 
with antibiotic producing organisms which are abundant in soil, where R. radiobacter often 
resides (Sood et al., 2010). Consistent with our results, resistance in R. radiobacter to 
cephalosporins and aminoglycoside antibiotics have been previously reported, this can 
include streptomycin and cefalotin (Chen et al., 2008; Sood et al., 2010). The observed 
resistance to trimethoprim has not previously been described, although it is of interest this 
organism is usually susceptible to a combination of trimethoprim with sulfamethoxazole (also 
known as co-trimoxazole) (Kaselitz et al., 2012; Sood et al., 2010). It is possible the 
resistance was acquired from antibiotic exposure since trimethoprim is permitted for use in 
the aquaculture industry in China and the R. radiobacter strain was isolated from a grass 
carp (Ctenopharyngodon Idella), one of the most commonly farmed fish species in China 
(Mo et al., 2015). 
 
5.2.5 Serratia species 
Serratia spp. are ubiquitous in the aquatic environment (Gillespie & Hawkey, 2006). Serratia 
spp. are responsible for causing opportunistic and nosocomial infections in hospitalised 
patients, mainly affecting immunocompromised patients (Traub, 2000). The two species of 
Serratia identified in this study, S. liquefaciens and S. fonticola, are potential human 
pathogens (Stock, Burak, Sherwood, Grüger, & Wiedemann, 2003). S. liquefaciens is the 
second most common strain of Serratia responsible for human infection and has been 
associated with bloodstream infection outbreaks in hospitals (Mahlen, 2011). In comparison, 
the pathogenicity of S. fonticola is lesser known but it has been infrequently identified in 
community acquired wound infection (Mahlen, 2011).     
 
Cefalotin, cefalexin and ampicillin: Serratia spp. (n=10) were resistant to cefalotin (100%), 
cefalexin (50%) and ampicillin (30%). This result is expected since Serratia species often 
demonstrate intrinsic resistance to a number of beta-lactams including ampicillin and 
cephalosporins (Mahlen, 2011). Consistent with our study findings, widespread resistance to 
cefalotin is commonly reported (Whitman, 2015). Previous studies found that all Serratia 
strains were resistant to cefalotin (Cooksey, Bannister, & Farrar, 1975; Freney et al., 1988; 
Zabransky, Hall, Day, & Needham, 1969). Higher levels of resistance than observed in our 
study were reported from the USA in 1969 when 100% of Serratia isolates (n = 15) were 
resistant to cefalexin (Zabransky et al., 1969). Resistance to ampicillin was previously 
reported in 42% of Serratia spp. isolated from fish and shrimp in Denmark (Noor Uddin et al., 
2013). In our study, resistance to ampicillin was only observed in S. fonticola and the S. 
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liquefaciens strains were all susceptible, suggesting a likely difference in natural 
susceptibility to ampicillin between different Serratia species.   
 
5.2.6 Yersinia species 
Yersinia spp. are ubiquitous in the environment (Verbikova, Borilova, Babak, & Moravkova, 
2018). Land animals have been identified as carriers of Yersinia spp., spreading the bacteria 
in the environment in their faeces (Novoslavskij et al., 2016). Of the strains identified in this 
study, Y. intermedia have been isolated from water and fish, and Y. kristensenii has been 
recovered from food, soil and fresh water sources (Whitman, 2015). Y. enterocolitica, a well-
documented strain of Yersinia which is a significant foodborne pathogen, was not identified 
in this study (Le Guern, Martin, Savin, & Carniel, 2016). The potential pathogenicity of the 
Yersinia spp. identified in this study, towards animals or humans is not fully understood since 
they are less known and less researched, although they have previously been isolated from 
patients suffering from acute diarrhoea and could possibly be opportunistic pathogens 
(Shilpi, Sarita, Sachin, & Jugsharan, 2007; Stock & Wiedemann, 2003). However, the risk 
appears low based on a previous finding that environmental strains of Y. kristensenii, (n = 
154) and Y. intermedia (n = 122) were not pathogenic to humans (Le Guern et al., 2016).  
 
Cefalotin and ampicillin: In this study, intermediate susceptibility to cefalotin was observed 
in Y. kristensenii (n=1) and resistance to cefalotin and ampicillin was observed in Y. 
intermedia (n=1). This finding is typical since Y. kristensenii, and Y. intermedia have 
previously demonstrated resistance to cefalotin and ampicillin (Ahmedy, Vidon, Delmas, & 
Lett, 1985; Freney et al., 1988). Resistance to beta-lactam antibiotics have been linked to 
the production of beta-lactamases in Y. enterocolitica (Verbikova et al., 2018). Therefore, the 
resistance observed in Y. kristensenii, and Y. intermedia, to ampicillin and cefalotin, may be 
from the production of beta-lactamases (Shilpi et al., 2007). The Y. kristensenii, and Y. 
intermedia were both isolated from the same crimson snapper (Lutjanus erythropterus) 
labelled wild caught. There are differences between typical antibiotic susceptibility patterns 
between Yersinia species (Stock & Wiedemann, 2003).  
 
Tetracycline, sulfonamides and streptomycin: The Yersinia spp. in this study were 
susceptible to the remaining antibiotics tested, including tetracycline and sulfonamides. This 
is line with expectations for strains of this species isolated from food, which generally 
demonstrate low levels of antibiotic resistance (Ahmedy et al., 1985). However, it was 
expected that Y. intermedia would demonstrate resistance to streptomycin, which this study 
did not find (Whitman, 2015).   
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5.2.7 Pseudomonas species 
Pseudomonas spp. are widely disseminated in the environment (Whitman, 2015). This study 
isolated Pseudomonas alcaligenes from fish which is unsurprising since this strain has 
previously been found in soil and water and has been implicated in the outbreak of infectious 
disease in aquaculture species (Xu et al., 2015). Limited information is available detailing its 
potential to cause disease in humans, however rare reports suggest it is an uncommon 
human pathogen which can cause opportunistic infection in the eyes, heart or lungs 
(Valenstein, Bardy, Cox, & Zwadyk, 1983).  
 
The susceptibility data for P. alcaligenes obtained in this study must be read with caution. 
There are incomplete susceptibility breakpoint guidelines for Pseudomonas spp. with the 
antibiotics tested. Therefore, the antimicrobial susceptibility results for P. alcaligenes. were 
inferred using interpretation criteria based on CLSI and EUCAST breakpoints for 
Enterobacteriaceae (CLSI, 2018b; EUCAST, 2018a).  
 
Cefalotin, ampicillin and cefalexin: This study found P. alcaligenes (n=1) was resistant to 
cefalotin, ampicillin and cefalexin. This resistance is typical since Pseudomonas spp. are 
intrinsically resistant to most beta-lactam antibiotics (Noor Uddin et al., 2013). This result is 
similar to an Australian study which found Pseudomonas spp. (n = 4) isolated from farmed 
fish were resistant to ampicillin, cefalexin and cefalotin (Akinbowale et al., 2006). Global 
studies found similar results, resistance to ampicillin was observed in 99% of Pseudomonas 
isolated from Vietnamese catfish (Nguyen et al., 2014) and resistance to cefalotin (75%) was 
found in clinical P. alcaligenes isolates in the USA (Gilardi, 1971).  
 
Nalidixic acid, trimethoprim, tetracycline and streptomycin: Our study did not detect 
resistance to nalidixic acid, trimethoprim, tetracycline and streptomycin in the one P. 
alcaligenes isolate. This result demonstrates less antibiotic resistance in comparison with 
results from previous Australian studies conducted in 2006 and 2007 (Akinbowale et al., 
2006; Akinbowale et al., 2007). In 2006, Pseudomonas spp. (n = 4) isolated from Australian 
farmed fish or water from crustacean rearing tanks were resistant to nalidixic acid (75%), 
trimethoprim (50%) and tetracycline (25%) (Akinbowale et al., 2006). In 2007, Pseudomonas 
spp. (n = 44) isolated from Australian farmed rainbow trout (Oncorhynchus mykiss) were 
resistant to streptomycin (43.2%) and trimethoprim (95.5%) (Akinbowale et al., 2007). The 
2007 study did not detect resistance to tetracycline, which is a similar result to this study 
(Akinbowale et al., 2007). The two previous studies isolated bacteria from aquaculture 
sources and it is possible that antibiotic resistance rates were higher due to exposure to 
antibiotics (Akinbowale et al., 2006). In contrast, this study analysed Pseudomonas spp. 
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isolated from Australian sourced Point Samson Rankin Cod (Epinephelus multinotatus) 
which is a fish that is likely wild caught and is not a common aquaculture species (Froese & 
Pauly, 2018). 
 
5.2.8 Buttiauxella species. 
Buttiauxella agrestis is ubiquitous in nature and has previously been isolated from water, soil 
and aquatic organisms (Antonello et al., 2014). The clinical significance of B. agrestis is 
limited and it has not been identified isolated in the hospital setting. There have been few 
reports outlining the potential pathogenicity of B. agrestis to humans, for instance, one rare 
case identified post caesarean surgical site infection due to B. agrestis which was believed 
to be community acquired (Antonello et al., 2014; Whitman, 2015).  
 
The B. agrestis (n=4) strains in the study were susceptible to the antibiotics tested, except 
for cefalotin. One isolate demonstrated resistance to cefalotin and the remaining three (75%) 
demonstrated intermediate susceptibility. Limited antimicrobial susceptibility data is available 
on B. agrestis since it is an uncommon human pathogen, however our findings appear 
consistent with available data. Cefalotin has previously been identified as being inactive 
against B. agrestis, a finding agreed with by a previous study which found 100% of B. 
agrestis isolates (n=13) were resistant to cefalotin (Freney et al., 1988; Whitman, 2015). 
Similar to our results, high levels of susceptibility were previously found in B. agrestis to a 
several antibiotics, including ampicillin and the combination of trimethoprim with 
sulfamethoxazole (co-trimoxazole) (Stone, O'Hara, Williams, McGowan, & Tenover, 2007) 
 
5.2.9 Pantoea species 
Pantoea spp. are commonly found in the environment, on plants and soil, and have been 
isolated from human and animal body fluids (Shubov, Jagannathan, & Chin-Hong, 2011). 
Pantoea agglomerans, previously named Enterobacter agglomerans, has been isolated from 
catfish effluent and diseased rainbow trout in previous antimicrobial susceptibility studies 
(Chuah et al., 2016; Saticioglu et al., 2018). P. agglomerans can cause disease in plants, 
animals and humans (Saticioglu et al., 2018). It is opportunistic, mainly causing infection in 
human wounds following trauma to the skin caused by plant material (Cruz, Cazacu, & Allen, 
2007). Nosocomial infection can occur in immunocompromised individuals or neonates 
exposed to P. agglomerans, causing pneumonia, UTIs and bacteremia (Saticioglu et al., 
2018).  
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This study found that P. agglomerans (n=1) were susceptible to eight antibiotics. This finding 
is in contrast to the expectation that P. agglomerans strains are naturally resistant to 
ampicillin and cefalotin (Whitman, 2015), although, P. agglomerans isolates from clinical 
samples have demonstrated variability in susceptibility to ampicillin and cephalosporins, 
including cefalotin (Cruz et al., 2007; Geere, 1977). Similar to this study’s result, P. 
agglomerans isolated from rainbow trout in a previous study were susceptible to all nine 
antibiotics tested, including sulfamethoxazole-trimethoprim, amoxicillin and tetracycline 
(Saticioglu et al., 2018).  
 
5.2.10 Pluralibacter species 
Pluralibacter gergoviae, previously known as Enterobacter gergoviae, is generally found in 
the environment, often in water (Whitman, 2015). There is limited information on the 
pathogenicity of P. gergoviae. Previous studies indicate P. gergoviae is a rare human 
pathogen which can cause nosocomial infections, it has been implicated in causing 
bacteremia in neonates, lower respiratory tract infection, UTIs and sepsis (Emeka et al., 
2012; Stock & Wiedemann, 2002). There is limited information on the anticipated 
susceptibility of P. gergoviae since it is of low clinical significance (Emeka et al., 2012; Stock 
& Wiedemann, 2002). In this study, P. gergoviae was susceptible to all antibiotics tested. 
This result is not surprising as susceptibility to a range of antibiotics, including ampicillin and 
cefalotin, has been demonstrated previously in P. gergoviae (Freney et al., 1988; Stock & 
Wiedemann, 2002).  
 
5.2.11 Country of Origin  
The country of origin may have an association with the presence of antibiotic resistance in 
Acinetobacter isolated from fish samples as there was more resistance seen to nalidixic 
acid, and streptomycin in the bacteria isolated from imported fish in comparison with 
Australian fish. However, the numbers in this study are quite small and it is therefore difficult 
to make confident inferences.  
 
The country of origin did not correlate with resistance in the Acinetobacter spp. to cefalotin, 
cefalexin and trimethoprim since the antibiotic resistance profile was similar for the 
Australian and imported Acinetobacter isolates. However, the country of origin may be 
responsible for the unexpected resistance in Acinetobacter to nalidixic acid (n = 1), ampicillin 
(n = 2) and streptomycin (n = 2). It is possible this resistance was acquired from antibiotic 
exposure since Acinetobacter spp. are likely to develop resistance in response to selective 
environment pressure (Maravić et al., 2016). The majority of the unexpected resistance in 
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the Acinetobacter spp. was observed in fish (n = 3) originating from Vietnam. One isolate 
was obtained from an Australian fish sample.  
 
Varied resistance to nalidixic acid, ampicillin and streptomycin was observed in 
Acinetobacter spp. isolated from snakehead fish (Ophiocephalus striatus, n = 1) and catfish 
(Pangasius hypophthalmus, n = 2) imported from Vietnam. Ampicillin resistance was 
observed in one Acinetobacter isolate obtained from crimson snapper (Lutjanus 
erythropterus) from Australia. It is likely the fish were farm raised since catfish and 
snakehead fish are common aquaculture species in Vietnam and crimson snapper is a 
farmed fish species in Australia (Cheng et al., 2018; Pham et al., 2015). It is highly likely that 
the fish were exposed to antibiotics during aquaculture production. There have been 
previous reports that nalidixic acid, ampicillin and streptomycin are used in Asian 
aquaculture; furthermore, ampicillin is approved for use in Vietnamese aquaculture (Binh et 
al., 2018; Done et al., 2015; Rico et al., 2012). Ampicillin is not permitted for use in 
Australian aquaculture but is permitted for disease treatment in certain agricultural animals 
(APVMA, 2014).  
 
There was no evidence that the country of origin was associated with different antibiotic 
resistance profiles in Serratia species tested. Resistance in Serratia spp. (n = 10) to 
cefalotin, cefalexin and ampicillin was typical for this genus which is often resistant to beta-
lactams (Mahlen, 2011). 
 
The other eight genera isolated in this study contained isolates obtained from either only fish 
of Australian origin or only from imported fish. Therefore, there is insufficient information to 
determine whether the country of origin is connected with different levels of antibiotic 
resistance in bacterial isolates. 
 
5.2.12 Health Risk (Infection) within Australia  
There are direct and indirect risks related to the presence of bacteria on seafood. The 
consumer is at a direct risk of developing an infection through consumption or contact with 
the pathogenic bacteria on food (Fletcher, 2015). The indirect risk is through the transfer of 
antibiotic resistant genes to pathogenic bacteria (Mo et al., 2015).  
 
Of the fifteen bacterial species identified in this study, A. hydrophilia is the single species 
that is a well-described foodborne pathogen (Praveen Kumar et al., 2016). There is a risk to 
the consumer that the bacteria will remain on the fish if it is not cooked adequately 
(Novoslavskij et al., 2016). During processing, poor hygiene and inadequate food handling 
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practices can result in the transmission of bacteria around the kitchen surfaces and 
equipment (Stein, 2011). Consequently, bacteria can be transmitted to raw food products or 
onto the consumer’s hands which poses a hazard to the consumer (Aitken et al., 2016). 
Contact with pathogenic bacteria on seafood with wounds and open skin can also cause 
human infection (Elbashir et al., 2018). A. hydrophila is an aquatic bacterium that is most 
likely to cause wound infection in a person handling fish with open skin (Alderman & 
Hastings, 1998). S. fonticola and S. maltophilia are also associated with rare community-
acquired wound infections and could also be a potential risk to the consumer by this 
pathway.  
 
The remaining bacteria identified in our study are not likely to pose a significant threat to 
human health via the contamination of fish products (Gillespie & Hawkey, 2006; Whitman, 
2015); because the pathogenicity is not well documented or the clinical significance is limited 
for these species (Buttiauxella spp., Yersinia spp., Pseudomonas spp., Pluralibacter spp. 
and Pantoea spp). Furthermore, Acinetobacter spp., Stenotrophomonas spp. and Rhizobium 
spp. are mainly opportunistic pathogens which cause nosocomial infections in the 
immunocompromised. Acinetobacter and Rhizobium are the only genera analysed in our 
study that may potentially have acquired antibiotic resistant genes compared to previous 
reports. These bacteria are both generally responsible for nosocomial infections. Therefore, 
the risk of an antibiotic resistant infection due to the consumption or handling of seafood is 
low.  
    
The indirect risk to human health is through the dissemination of antibiotic resistant genes 
between bacteria by horizontal gene transfer (Capita & Alonso-Calleja, 2013). Antibiotic 
resistant gene exchange can occur between environmental bacteria and human pathogens, 
leading to infection which is difficult to treat with existing medicines (Finley et al., 2013). The 
exchange of antibiotic resistant genes between bacteria can occur at any stage of seafood 
production, including in the aquatic environment, processing and during storage. 
Acinetobacter, one of the predominant bacteria genera identified in this study are highly 
resistant to multiple antibiotics and there is a risk of them disseminating antibiotic resistant 
mobile genetic elements to other bacteria in the aquatic environment (Maravić et al., 2016). 
In our study, Acinetobacter spp. possibly acquired resistance to nalidixic acid, streptomycin 
and ampicillin. Antibiotic resistance could potentially transfer to pathogens which cause 
infections in humans, increasing the risk of antibiotic resistant infections.   
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5.3 Clostridium difficile presence in Fish 
C. difficile, a bacterium often found in human and animal faeces, is a human pathogen that 
may cause infection when ingested (Warriner, Xu, Habash, Sultan, & Weese, 2017). It is 
theorised that C. difficile could potentially cause foodborne infection and it has previously 
been isolated from food (Lim et al., 2018). Antibiotic exposure is a significant risk factor for 
C. difficile infection (Putsathit et al., 2015). Therefore, the use of antibiotics in integrated 
agricultural and aquaculture farms may encourage the transmission of C. difficile infection.  
 
C. difficile was not detected in all fish samples (n = 44) from this study. This finding is lower 
than reported previously in other countries which have detected C. difficile in beef, chicken 
and seafood (Warriner et al., 2017). Furthermore, a previous study detected C. difficile in 
4.8% of seafood (n = 119) in Canada (Metcalf et al., 2011). A similar prevalence was 
observed in a US study which detected C. difficile in 4.5% of shellfish and finfish samples (n 
= 67) (Norman et al., 2014). In China, bacteria of the genera Clostridium have been detected 
in water and sediment samples obtained from aquaculture, however, this study did not 
identify the bacteria to species level and the presence C. difficile was not confirmed (Xiong 
et al., 2015).  
 
The prevalence of C. difficile in food has previously been attributed to contamination with 
animal manure or raw sewage pollution (Lim et al., 2018; Norman et al., 2014). Therefore, 
the result in this study suggests that the fish were potentially sourced from an environment 
without faecal contamination. There was no difference between the result for the fish from 
Australia and the imported fish despite differences in farming practices, such as integrated 
farming of agricultural animals with aquaculture which is popular in Asian countries. The 
Australian consumer does not appear to be at risk of C. difficile infection from the 
consumption of seafood, irrespective of the product’s country of origin. 
 
5.4 Bacterial Load 
One third of the fish samples (n = 44) analysed did not demonstrate any bacterial growth on 
MAC agar. This finding is in contrast with previous studies that isolated bacteria from all 
analysed fish samples (Fuentes-Amaya, Munyard, Fernandez-Piquer, & Howieson, 2016; 
Kulawik et al., 2016). The difference is likely attributed to our study design which was 
selective for the growth of Gram negative bacteria. The bacterial load obtained is limited to 
organisms that can grow on MAC and represents a portion of the total bacterial colonisation 
of the fish samples. In comparison, previous studies calculated the total viable count (TVC) 
of bacteria isolated from fish using less restrictive agar, such as plate count agar (Fuentes-
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Amaya et al., 2016; Kulawik et al., 2016). Therefore, our figures obtained are likely an 
underestimate of the TVC.   
 
The remaining two-thirds of fish samples demonstrated bacterial growth, ranging from 100 to 
6.6 × 105 MCFU/g. There was no significant difference between the levels of bacteria 
isolated from Australian and imported fish. All results were within the satisfactory 
microbiological assessment reference limit for raw fish (< 106 CFU/g) (Health Protection 
Agency, 2009). Due to the selective nature of our culture, the MCFU is an underestimate 
and the total CFU results may have been close to, or over, the satisfactory limit. Raw fish 
typically have high bacterial counts due to the presence of naturally occurring bacteria 
(FSANZ, 2018b). Based on the estimated Gram negative MCFU/g results there is limited risk 
to the consumer, particularly since the fish in this study are raw which must be cooked 
before consumption (Committee on the Review of the Use of Scientific Criteria and 
Performance Standards for Safe Food, 2003).  
 
5.5 Study Limitations 
This study focused on the isolation of Gram negative bacteria and there are several 
limitations which reduced the range of bacterial species growth, including the use of 
selective media, incubation time and incubation temperature. Therefore, the type of bacteria 
grown from the fish samples was reduced in variety. Another limitation is the small number 
of colonies which were assessed in preliminary tests and consequently, the small sample 
size. This study was conducted in Perth in Western Australia which is a limited geographical 
area for sample collection and may limit the generalisation of the findings to other regions in 
Australia. 
 
6.0 Summary and Recommendations  
There were two components to this study, an analysis of antibiotic residues in seafood and 
the presence of antibiotic resistant bacteria on fish. Firstly, a survey tested the concentration 
of eight antibiotics in 253 seafood products originating in 22 countries, purchased throughout 
WA. This study determined the concentration of eight antibiotics were below the LOR in 
99.6% (n=252) of the seafood samples sold in Australia. Compliance with the maximum 
allowable antibiotic limits stipulated in the ANZFSC and the Food Act 2008 (WA) were 
observed in 99.6% of the seafood tested. One sample contravened the legislation with the 
detection of erythromycin in seafood sticks originating from Thailand. However, the 
concentration of erythromycin did not pose an immediate threat to human health, based on 
guidelines provided by the Codex Alimentarius Commission.  
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The high compliance in this study suggests that seafood sold in Australia is free from 
antibiotic residue contamination, except for one sample imported from Thailand. Our result 
suggests an increase in compliance compared to the AQIS survey conducted by the 
Australian government in 2006 and 2007. Our result contrasts with global studies which have 
found an increased occurrence of antibiotic residues contaminating seafood produced 
throughout Asia. The difference is likely attributed to Australia’s strict border testing and food 
safety legislation, in comparison to Asian countries. Asian farmers may have an increased 
awareness of the legislative requirements to export seafood to Australia and comply to 
protect their profits. It has been determined that there are different standards in Aquaculture 
production in Asia depending on whether the product is intended for export or the domestic 
market. Fish farmers are instructed to wait certain withdrawal periods after using antibiotics 
to ensure that antibiotic residues are not present. Australian border tests do not assess food 
for antibiotic resistant bacteria. Antibiotic resistance studies should be performed on aquatic 
bacteria to assess the public health risk associated with antibiotic use in aquaculture more 
precisely. 
 
Secondly, our study analysed 44 pre-packaged fish samples originating in seven countries 
and purchased in Perth, WA for the presence of antibiotic resistant Gram negative bacteria. 
Thirty-five isolates comprising fifteen different environmental bacterial species from ten 
different genera were identified by MALDI-TOF. Potential pathogens were identified which 
may pose a direct risk to the consumer. A. hydrophilia is a possible foodborne pathogen and 
wound infection could potentially occur in the kitchen from open skin contact with A. 
hydrophilia, S. maltophilia or S. fonticola. There is an additional indirect risk to public health 
with Acinetobacter spp. potentially spreading antibiotic resistant genes in the environment, 
potentially to pathogenic species. The other isolates (Buttiauxella, Yersinia, Rhizobium, 
Pseudomonas, Pantoea, Pluralibacter species) are rare human pathogens which generally 
cause nosocomial infections and therefore are not likely to be a direct risk to the consumer 
via fish consumption. 
 
The disc diffusion test was conducted to test 35 bacteria for antibiotic resistance to eight 
antibiotics. Most of the resistance found was intrinsic. However, potential acquired antibiotic 
resistance was observed in four Acinetobacter species and a Rhizobium isolate which were 
isolated from commonly farmed fish from Australia (n = 1), China (n = 1) and Vietnam (n = 
3). It is possible the fish may have been exposed to antibiotics during the production cycle as 
antibiotic misuse and overuse in the aquaculture industry have previously been linked to an 
increase in antibiotic resistance in environmental bacterial strains. However, this result must 
be read with caution since there are limited guidelines for these species. The influence of 
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country of origin on the presence of antibiotic resistance in bacteria isolated from locally and 
internationally sourced fish sold in Australia requires further investigation with a bigger 
sample size.  
 
Our results demonstrate that in Australia, the presence of antibiotic resistant bacteria on 
seafood may currently pose a more significant threat to public health than antibiotic residue 
contamination. There is a gap in knowledge regarding the extent of the public health impact 
associated with the occurrence of antibiotic resistant bacteria in the food chain and antibiotic 
resistant genes transferring to human pathogens from aquatic bacteria. A detailed 
investigation is required to assess the extent of antibiotic resistance in Gram negative and 
Gram positive bacteria to a broader range of antibiotics which are important for human 
medicine. It is also suggested that future studies include analysis for antibiotic resistant 
bacteria in seafood products which are eaten raw, such as sashimi or ceviche, since the risk 
to the consumer is heightened without the cooking step to eliminate bacteria. Furthermore, it 
is recommended that future studies focus predominantly on farmed fish products which 
should be evaluated more regularly and with more rigour.  
 
It is also recommended that the Australian government create new policy and allocate 
funding for routine surveillance of antibiotic resistance in bacteria isolated from domestic and 
imported food of animal origin, to monitor this potential risk to human public health. This 
matter was raised as a recommended priority area of action in the Australian Government’s 
National Antimicrobial Resistance Strategy (Department of Health & Department of 
Agriculture, 2015). It is anticipated that action will be taken by 2019 to address this uncertain 
risk, however, it is of concern that some recommendations outlined in JETCAR’s 1999 report 
to mitigate the risk of antibiotic resistance have not yet been implemented by the Australian 
government (APVMA, 2017). 
 
In conclusion, our study found the risk of toxicity or allergy to the Australian consumer is low 
from the consumption of seafood. Secondly, our results suggest that there is possible risk to 
human health from the development of antibiotic resistance in bacteria on fish. Further 
research is required to assess the public health risk to the consumer posed by the presence 
of antibiotic resistant bacteria in the food chain.  
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8.0 Appendices 
Appendix A 
Microbact 12A Bacterial Identification Procedure 
 
One isolated colony was picked from the TSA plate with a sterile loop, emulsified in a 2.5 mL 
of sterile saline solution and then mixed to prepare a homogenous suspension. Each 
Microbact well was inoculated with 100 µL of the bacterial suspension. Sterile Mineral Oil 
(ThermoFisher Scientific Australia Pty Ltd, Scoresby, VIC) was added to wells 1, 2 and 3. 
The strips were incubated at 37°C for between 18 and 24 hours. After the incubation period 
reagents were added to the appropriate wells of the Microbact test strip (Table 1A). The 
wells were assessed visually for colour changes and the reaction was deemed as positive or 
negative according to the manufacturer’s instructions. Results were recorded and the 
Microbact wells were photographed to keep an electronic record (Figure 1A). To identify the 
bacteria to genus level, the biochemical reactions were interpreted in accordance with the 
Advanced Bacterial Identification Software (Costin & Ionut, 2017). 
 
For each new Microbact 12A identification kit that was used, a quality control test was 
conducted using E. coli ATCC 25922. One isolated colony was selected and tested as 
described above. The identification information was compared to the expected parameters 
for E. coli ATCC 25922 (Table 2A) (Thermo Fisher Scientific Inc., 2018).  
 
 
 
 
Figure 1A. Microbact test results for fish sample 9A(3) (Buttiaxuella spp.) and 10A(1) 
(Serratia spp.), following the incubation period and the addition of reagents.   
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Table 1A. Microbact 12A Biochemical Identification Kit. Source: Thermo Fisher Scientific 
Inc. (2018).  
Well 
Number 
Reaction Principle Mineral Oil 
Added before 
Incubation 
Reagent(s) 
Added after 
Incubation 
Time before 
evaluation 
1 Lysine Decarboxylase Yes N/A Immediately 
2 Ornthine Decarboxylase Yes N/A Immediately 
3 Hydrogen Sulfide Production Yes N/A Immediately 
4 Glucose fermentation No N/A Immediately 
5 Mannitol fermentation No N/A Immediately 
6 Xylose fermentation No N/A Immediately 
7 Hydrolysis of β-nitrophenyl-
β-d-galactosidase (ONPG) 
by action of β-galactosidase 
No N/A Immediately 
7 Nitrates reduction (after 
reading the ONPG reaction) 
No 1 drop of Nitrate 
A and 1 drop of 
Nitrate B 
2 minutes 
8 Indole production from 
tryptophan 
No 2 drops of Indole 2 minutes 
9 Urea hydrolysis No N/A Immediately 
10 Acetoin production (Vogues-
Proskaür reaction) 
No 1 drop of VPI and            
1 drop of VPII 
15 minutes 
11 Citrate utilization No N/A Immediately 
12 Production of indolepyruvate 
by deamination of 
tryptophan 
No 1 drop of TDA Immediately 
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Table 2A. Expected results on the Microbact 12A with E. coli ATCC 25922. Note. Source: 
Thermo Fisher Scientific Inc. (2018).  
 
Well Number Reaction Principle Expected Result 
1 Lysine Decarboxylase + 
2 Ornthine Decarboxylase + 
3 Hydrogen Sulfide Production - 
4 Glucose fermentation + 
5 Mannitol fermentation + 
6 Xylose fermentation + 
7 Hydrolysis of β-nitrophenyl-β-d-galactosidase (ONPG) by 
action of β-galactosidase 
+ 
7 Nitrates reduction (after reading the ONPG reaction) + 
8 Indole production from tryptophan + 
9 Urea hydrolysis - 
10 Acetoin production (Vogues-Proskaür reaction) - 
11 Citrate utilization - 
12 Production of indolepyruvate by deamination of tryptophan - 
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Appendix B 
Details of the Analysed Fish Products 
Table 1B.  Details of the 44 analysed fish products. 
 
ID 
No. 
Fish Label 
Name  
Fish Scientific 
name 
Wild or 
farmed* 
Country of 
Origin 
MALDI-TOF 
Bacterial 
Identification 
MALDI-TOF 
Score Value 
MCFU/g 
1A Blue spot 
emperor 
Lethrinus 
punctulatus 
Wild Australia Serratia fonticola 
2.597 6 X 10^ 3 
2A Crimson 
Snapper 
Lutjanus 
erythropterus 
N/A Australia Acinetobacter 
haemolyticus 
2.342 9 X 10^ 2 
3A Sweetlips 
Bream 
Diagramma 
labiosum 
N/A Australia N/A N/A 0 
4A Lake argyle 
silver 
cobbler fillet 
Neoarius midgleyi 
N/A Australia Buttiauxella agrestis 
 
2.09 1.02 X 10^ 5 
5A Blue Spot 
Emperor 
Lethrinus 
punctulatus 
N/A Australia Aeromonas 
salmonicida  2.619 6.6 X 10^ 5 
5A Blue Spot 
Emperor 
Lethrinus 
punctulatus 
N/A Australia Aeromonas 
hydrophila  2.457 6.6 X 10^ 5 
6A Saddletail 
Snapper 
Lutjanus 
malabaricus 
N/A Australia N/A N/A 0 
7A Kingfish 
Fillet 
Seriola lalandi 
N/A Australia Serratia fonticola 
 
2.423 2 X 10^ 2 
8A Point 
Samson 
Rankin Cod 
Epinephelus 
multinotatus 
N/A Australia Pseudomonas 
alcaligenes  
 
2.05 4 X 10^ 1 
8A Point 
Samson 
Rankin Cod 
Epinephelus 
multinotatus 
N/A Australia Serratia liquefaciens 
2.444 4 X 10^ 1 
9A Painted 
Sweetlip 
Diagramma 
labiosum 
N/A Australia Buttiauxella agrestis  
 
2.099 3.6 X 10^ 4 
10A Sea Bream 
Filllets 
Gymnocranius 
grandoculis 
N/A Australia Pantoea 
agglomerans 2.334 6.7 X 10^ 3 
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10A Sea Bream 
Filllets 
Gymnocranius 
grandoculis 
N/A Australia Serratia liquefaciens 
 2.369 6.7 X 10^ 3 
11A Threadfin 
Pinky 
Bream 
Nemipterus 
furcosus 
N/A Australia Buttiauxella agrestis 
 2.178 6.5 X 10^ 4 
11A Threadfin 
Pinky 
Bream 
Nemipterus 
furcosus 
N/A Australia Serratia liquefaciens 
2.465 6.5 X 10^ 4 
12A Saddletail 
Snapper 
Lutjanus 
malabaricus 
N/A Australia Buttiauxella agrestis  
 2.202 5.5 X 10^ 4 
12A Saddletail 
Snapper 
Lutjanus 
malabaricus 
N/A Australia Serratia liquefaciens 
2.424 5.5 X 10^ 4 
13A Moses 
Snapper 
Fillet 
Lutjanus russellii N/A Australia Aeromonas 
hydrophila 
2.574 2.4 X 10^ 4 
14A Crimson 
Snapper 
Lutjanus 
erythropterus 
Wild Australia Yersinia kristensenii  
2.545 7 X 10^ 2 
14A Crimson 
Snapper 
Lutjanus 
erythropterus 
Wild Australia Yersinia intermedia 
2.552 7 X 10^ 2 
15A Perch Pearl Glaucosoma 
buergeri 
Wild Australia N/A N/A 0 
16A Trevally Pseudocaranx 
georgianus 
Wild Australia Serratia liquefaciens 
 
2.508 1 X 10^ 2 
17A Mandurah 
Mullet Fillets 
Mugil cephalus 
N/A Australia Serratia fonticola 
 
2.404 2 X 10^ 2 
18A Coral Trout Plectropomus 
leopardus 
N/A Australia N/A N/A 0 
19A Red 
Emperor 
Lutjanus sebae N/A Australia N/A N/A 0 
20A Spangled 
Emperor 
Lethrinus 
nebulosus 
N/A Australia Acinetobacter 
haemolyticus 
 
2.421 5 X 10^ 2 
21A Goldband 
Snapper 
Pristipomoides 
multidens 
N/A Australia Acinetobacter 
haemolyticus 
 
2.451 7 X 10^ 2 
1B Basa  Pangasius 
hypophthalmus 
N/A Vietnam Acinetobacter 
haemolyticus  
 
2.433 6 X 10^ 2 
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2B Emperor 
Fillets  
Lethrinus sp. Wild Vietnam N/A N/A 1.2 X 10^ 3 
3B Basa  Pangasius 
hypophthalmus 
N/A Vietnam Acinetobacter 
haemolyticus  
 
2.399 1.3 X 10^ 3 
4B Threadfin 
Bream 
Nemipterus 
japonicus 
Wild India N/A N/A 0 
5B Grouper  Epinephelussp. Wild Indonesia N/A N/A 2.6 X 10^ 3 
6B Snakehead 
fish cutlets  
Ophiocephalus 
striatus 
N/A Vietnam Acinetobacter 
ursingii  2.316 7.1 X 10^ 3 
6B Snakehead 
fish cutlets  
Ophiocephalus 
striatus 
N/A Vietnam Pluralibacter 
gergoviae 
 
2.403 7.1 X 10^ 3 
7B Basa fillets  Pangasius 
hypophthalmus 
N/A Vietnam Acinetobacter 
haemolyticus 
 
2.374 4.3 X 10^ 3 
8B Basa White 
Catfish  
Pangasius 
hypophthalmus 
N/A Vietnam Acinetobacter 
haemolyticus 
 
2.444 1 X 10^ 3 
9B Alaska 
Pollack  
Theragra 
chalcogramma 
N/A Korea N/A N/A 0 
10B Monkfish Lophius litulon Wild China N/A N/A 0 
11B Smallscale 
Tonguesole  
Cynoglossus 
Microlepis 
N/A Vietnam N/A N/A 0 
12B Basa  Pangasius 
hypophthalmus 
Farmed Vietnam Serratia fonticola 
 
2.483 1 X 10^ 2 
13B Hoki  Macruronus 
novaezelandiae 
Wild New 
Zealand 
Serratia liquefaciens 
2.446 1 X 10^ 2 
14B Hoki  Macruronus 
novaezelandiae 
Wild China N/A N/A 3 X 10^ 2 
15B Basa  Pangasius 
hypophthalmus 
Farmed Vietnam Acinetobacter 
haemolyticus 
 
2.362 1.7 X 10^ 3 
16B Basa  Pangasius 
hypophthalmus 
N/A Vietnam N/A N/A 0 
17B Basa steak  Pangasius 
hypophthalmus 
Farmed Vietnam N/A N/A 0 
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18B Grass Carp 
Cutlet 
Ctenopharyngodo
n idella 
N/A China Rhizobium 
radiobacter 
 
2.256 1 X 10^ 2 
19B Ribbon Fish  Trichiurus 
Lepturus 
N/A Vietnam N/A N/A 0 
20B Basa cutlets  Pangasius 
hypophthalmus 
N/A Vietnam Stenotrophomonas 
maltophilia 
 
2.3 1 X 10^ 2 
21B Sweetlips 
Snapper 
Fillets 
Lutjanus 
lemniscatus 
N/A Indonesia Stenotrophomonas 
maltophilia 
 
2.3 4 X 10^ 2 
22B Red Spot 
Emperor 
Lethrinus lentjan N/A Indonesia N/A N/A 0 
23B Goldband 
Snapper 
Pristipomoides 
multidens 
N/A Indonesia Acinetobacter junii 
 
2.464 1 X 10^ 3 
* N/A = inadequate labelling information  
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Appendix C 
Disc Diffusion Results 
Table 1C. Zone diameter results from the disc diffusion test. Zone diameter interpretation 
determined by EUCAST or CLSI and coloured by susceptibility result (green = susceptible, 
yellow = intermediate, red = resistant).  
 
Bacterial Species ID no. Zone Diameter (nearest whole mm) 
TE* CEF* AMP* CXN* NA* S* TMP* SUL* 
Aeromonas  5A (2) 30 0 0 20 33 14 15 34 
Aeromonas  5A (3) 30 0 0 17 34 14 22 36 
Aeromonas  13A (3) 30 22 0 20 35 17 26 34 
Buttiauxella 4A (1) 27 16 22 22 27 19 30 38 
Buttiauxella 9A (3) 27 14 19 20 27 19 32 32 
Buttiauxella 11A (2) 27 15 22 20 27 19 34 38 
Buttiauxella 12A (2) 28 15 22 19 28 19 34 38 
Pantoea  10A (2) 30 25 25 24 35 28 40 40 
Pluralibacter 6B (4) 24 21 23 25 21 22 22 36 
Serratia  1A (2) 28 0 11 N/A 33 19 34 36 
Serratia  7A (2) 26 0 10 12 31 21 28 34 
Serratia  8A (3) 20 0 17 11 30 22 23 32 
Serratia  10A (1) 22 0 20 14 33 23 25 30 
Serratia  11A (1) 21 12 19 21 31 22 25 34 
Serratia  12A (3) 22 10 22 15 32 20 24 31 
Serratia  16A (1) 25 0 14 10 33 22 28 36 
Serratia  17A (2) 27 0 0 13 31 21 28 32 
Serratia  12B (1) 29 0 18 20 36 23 32 30 
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Serratia  13B (1) 21 0 20 13 32 22 26 30 
Yersinia 14A (1) 28 0 12 22 32 30 24 38 
Yersinia 14A (2) 29 17 23 21 34 21 28 34 
Acinetobacter 2A (2) 25 0 11 0 25 23 0 34 
Acinetobacter 20A (2) 22 0 19 9 24 19 10 38 
Acinetobacter 21A (1) 22 0 18 9 23 18 10 36 
Acinetobacter 1B (1) 18 8 17 N/A 19 21 0 29 
Acinetobacter 3B (2) 19 0 0 0 28 0 10 44 
Acinetobacter 6B (3) 27 0 22 14 11 26 13 41 
Acinetobacter 7B (2) 20 12 21 13 23 9 14 32 
Acinetobacter 8B (1) 20 8 18 10 23 18 0 34 
Acinetobacter 15B (1) 28 0 15 8 27 20 12 32 
Acinetobacter 23B (2) 23 14 25 18 26 24 12 39 
Pseudomonas 8A (1) 28 0 9 0 24 19 20 50 
Rhizobium  18B (1) 37 0 12 18 22 0 0 40 
Stenotrophomonas 20B (1) 26 0 0 0 28 24 0 44 
Stenotrophomonas 21B (4) 32 0 19 0 28 10 0 46 
* TE = tetracyline, CEF = cefalotin, AMP = ampicillin, CXN = cefalexin, NA = nalidixic acid, S 
= streptomycin, TMP = trimethoprim, SUL =  sulfonamides. 
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Appendix D 
Quality Control Results for Disc Diffusion 
 
Figure 1D. The diameter of E. coli ATCC 25922 resistance zones with the eight antibiotics 
using the disc diffusion test conducted over 8 weeks. The upper and lower target range are 
indicated with the black dashed lines. There is no provided range for E. coli ATCC 25922 
with sulfonamides.    
 
 
 
